Author: "Auranen A" / Search Limiters: Peer Reviewed - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Auranen A"' showing total 666 results

Start Over Author "Auranen A" Search Limiters Peer Reviewed

666 results on '"Auranen A"'

1. γ+66-Ray spectroscopy above the 9γ+66 isomeric state in the N = Z nucleus γ+66As

Author: Joukainen, Henna, Ruotsalainen, Panu, Sarén, Jan, Srivastava, Praveen C., Patel, Deepak, Julin, Rauno, Auranen, Kalle, Ge, Zhuang, Grahn, Tuomas, Greenlees, Paul, Illana, Andres, Jutila, Henri, Leino, Matti, Louko, Jussi, Luoma, Minna, Ojala, Joonas, Pakarinen, Janne, Rahkila, Panu, Sandzelius, Mikael, Tann, Holly, Uusitalo, Juha, and Zimba, George L.
Published: 2024
Full Text: View/download PDF

2. Direct measurement of three different deformations near the ground state in an atomic nucleus

Author: Adrian Montes Plaza, Janne Pakarinen, Philippos Papadakis, Rolf-Dietmar Herzberg, Rauno Julin, Tomás R. Rodríguez, Andrew D. Briscoe, Andrés Illana, Joonas Ojala, Panu Ruotsalainen, Eetu Uusikylä, Betool Alayed, Ahmed Alharbi, Odette Alonso-Sañudo, Kalle Auranen, Ville Bogdanoff, Jamie Chadderton, Arwin Esmaylzadeh, Christoph Fransen, Tuomas Grahn, Paul T. Greenlees, Jan Jolie, Henna Joukainen, Henri Jutila, Casper-David Lakenbrink, Matti Leino, Jussi Louko, Minna Luoma, Adam McCarter, Bondili Sreenivasa Nara Singh, Panu Rahkila, Andrea Raggio, Jorge Romero, Jan Sarén, Maria-Magdalini Satrazani, Marek Stryjczyk, Conor M. Sullivan, Álvaro Tolosa-Delgado, Juha Uusitalo, Franziskus von Spee, Jessica Warbinek, and George L. Zimba
Subjects: Astrophysics, QB460-466, Physics, QC1-999
Abstract: Abstract Atomic nuclei serve as prime laboratories for investigations of complex quantum phenomena, where minor nucleon rearrangements cause significant structural changes. 190Pb is the heaviest known neutron-deficient Pb isotope that can exhibit three distinct shapes: prolate, oblate, and spherical, with nearly degenerate excitation energies. Here we report on the combined results from three state-of-the-art measurements to directly observe these deformations in 190Pb. Contrary to earlier interpretations, we associate the collective yrast band as predominantly oblate, while the non-yrast band with higher collectivity follows characteristics of more deformed, predominantly prolate bands. Direct measurement of the $$E0({0}_{2}^{+}\to {0}_{1}^{+})$$ E 0 ( 0 2 + → 0 1 + ) transition and γ-e − coincidence relations allowed us to locate and firmly assign the $${0}_{2}^{+}$$ 0 2 + state in the level scheme and to discover a spherical $${2}_{3}^{+}$$ 2 3 + state at 1281(1) keV with $$B(E2;{2}_{3}^{+}\to {0}_{1}^{+})=1.2(3)$$ B ( E 2 ; 2 3 + → 0 1 + ) = 1.2 ( 3 ) W.u. These assignments are based purely on observed transition probabilities and monopole strength values, and do not rely on model calculations for their interpretation.
Published: 2025
Full Text: View/download PDF

3. Development of Real-Time Surveillance for Serious Adverse Events in a Pragmatic Clinical Trial Using National Registers in Finland

Author: Nieminen TA, Palmu AA, Auvinen R, Kulathinal S, Auranen K, Syrjänen RK, Nieminen H, Mallett Moore T, Pepin S, and Jokinen J
Subjects: vaccine safety, bayesian statistics, pharmacovigilance, observational study, register-based study, pragmatic trial, Infectious and parasitic diseases, RC109-216
Abstract: Tuomo A Nieminen,1,2 Arto A Palmu,1,3 Raija Auvinen,4 Sangita Kulathinal,2 Kari Auranen,5 Ritva K Syrjänen,1,6 Heta Nieminen,1,6 Tamala Mallett Moore,7 Stephanie Pepin,8 Jukka Jokinen1 1Data and Analytics, Finnish Institute for Health and Welfare (THL), Helsinki, Finland; 2Department of Mathematics and Statistics, University of Helsinki, Helsinki, Finland; 3Management Team, FVR – Finnish Vaccine Research, Tampere, Finland; 4Internal Medicine, Helsinki University Hospital, Helsinki, Finland; 5Mathematics and Statistics and Clinical Medicine, University of Turku, Turku, Finland; 6RWE Unit, FVR – Finnish Vaccine Research, Tampere, Finland; 7Global Pharmacovigilance, Sanofi, Swiftwater, PA, USA; 8Global Clinical Development, Sanofi, Marcy-l’Étoile, FranceCorrespondence: Tuomo A Nieminen, Data and Analytics, Finnish Institute for Health and Welfare, Mannerheimintie 166, Helsinki, 00271, Finland, Tel +358 29 524 7534, Email tuomo.nieminen@thl.fiPurpose: We developed a hybrid safety surveillance approach for a large, pragmatic clinical trial of a high-dose quadrivalent influenza vaccine (QIV-HD), using both active and passive data collection methods. Here, we present the methods and results for the passive register-based surveillance of serious adverse events (SAEs), which replaced conventional SAE reporting during the trial.Patients and Methods: The trial recruited over 33,000 older adults of whom 50% received the QIV-HD while the rest received a standard-dose vaccine (QIV-SD) as a control vaccine. We collected diagnoses related to all acute hospitalizations during the six months following vaccination from national registers. During the blinded phase of the trial, we utilized a cohort study design and compared the incidences of 1811 ICD10 diagnosis groups (SAE categories) between the trial population and older adults vaccinated with the QIV-SD outside the trial, either during the study or the previous influenza season. Based on a real-time probabilistic comparison, we flagged SAE categories with higher incidence in the trial population and then evaluated possible causal associations between each flagged category and the trial intervention.Results: Our novel approach to safety surveillance provided information, which we could evaluate in real-time during the trial. The trial participants experienced 1217 hospitalizations related to any SAE categories, contributed by 941 patients. We flagged 10 SAE categories for further analysis during the study but based on further data review, none presented strong evidence of causality with vaccination.Conclusion: Safety signals can be detected and evaluated in real-time during a pragmatic vaccine trial with register-based follow-up, utilizing passive data collection and population level comparison. Compared to conventional methods of safety follow-up, this method is likely to be more comprehensive, objective and resource effective.Keywords: vaccine safety, Bayesian statistics, pharmacovigilance, observational study, register-based study, pragmatic trial
Published: 2024

4. Hypothesis-driven mediation analysis for compositional data: an application to gut microbiome

Author: Kartiosuo, Noora, Nevalainen, Jaakko, Raitakari, Olli, Pahkala, Katja, and Auranen, Kari
Subjects: Statistics - Applications
Abstract: Biological sequencing data consist of read counts, e.g. of specified taxa and often exhibit sparsity (zero-count inflation) and overdispersion (extra-Poisson variability). As most sequencing techniques provide an arbitrary total count, taxon-specific counts should ideally be treated as proportions under the compositional data-analytic framework. There is increasing interest in the role of the gut microbiome composition in mediating the effects of different exposures on health outcomes. Most previous approaches to compositional mediation have addressed the problem of identifying potentially mediating taxa among a large number of candidates. We here consider causal inference in compositional mediation when a priori knowledge is available about the hierarchy for a restricted number of taxa, building on a single hypothesis structured in terms of contrasts between appropriate sub-compositions. Based on the theory on multiple contemporaneous mediators and the assumed causal graph, we define non-parametric estimands for overall and coordinate-wise mediation effects, and show how these indirect effects can be estimated from empirical data based on simple parametric linear models. The mediators have straightforward and coherent interpretations, related to specific causal questions about the interrelationships between the sub-compositions. We perform a simulation study focusing on the impact of sparsity and overdispersion on estimation of mediation. While unbiased, the precision of the estimators depends, for any given magnitude of indirect effect, on sparsity and the relative magnitudes of exposure-to-mediator and mediator-to-outcome effects in a complex manner. We demonstrate the approach on empirical data, finding an inverse association of fibre intake on insulin level, mainly attributable to direct rather than indirect effects.
Published: 2023
Full Text: View/download PDF

5. Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial

Author: Mirza, Mansoor R., Bjørge, Line, Marmé, Frederik, Christensen, René DePont, Gil-Martin, Marta, Auranen, Annika, Ataseven, Beyhan, Rubio, Maria Jesús, Salutari, Vanda, Luczak, Adam A., Runnebaum, Ingo B., Redondo, Andrés, Lindemann, Kristina, Trillsch, Fabian, Ginesta, M. Pilar Barretina, Roed, Henrik, Kurtz, Jean-Emmanuel, Petersson, Karen S., Nyvang, Gitte-Bettina, and Sehouli, Jalid
Published: 2025
Full Text: View/download PDF

6. Increasing trend of antimicrobial resistance among methicillin-resistant Staphylococcus aureus strains in Southwest Finland, 2007–2016: An analysis of shifting strain dynamics and emerging risk factors

Author: Silvola, Jaakko, Gröndahl-Yli-Hannuksela, Kirsi, Hirvioja, Tiina, Rantakokko-Jalava, Kaisu, Kanerva, Mari, Auranen, Kari, Marttila, Harri, Junnila, Jenna, and Vuopio, Jaana
Published: 2025
Full Text: View/download PDF

7. Direct observation of E0 transitions in 188Pb through in-beam spectroscopy

Author: P. Papadakis, J. Pakarinen, A.D. Briscoe, D.M. Cox, R. Julin, K. Auranen, T. Grahn, P.T. Greenlees, K. Hadyńska-Klek, A. Herzáň, R.-D. Herzberg, U. Jakobsson, S. Juutinen, J. Konki, M. Leino, A. Mistry, D. O'Donnell, P. Peura, P. Rahkila, P. Ruotsalainen, M. Sandzelius, J. Sarén, C. Scholey, S. Stoltze, J. Sorri, J. Uusitalo, and K. Wrzosek-Lipska
Subjects: In-beam spectroscopy, Shape coexistence, Internal conversion electrons, Physics, QC1-999
Abstract: Competing configurations, assigned with three different shapes, are mixed at low angular momentum in the neutron-deficient 188Pb nucleus. Here, we present a simultaneous conversion electron and γ-ray in-beam spectroscopic precision measurement employing the sage spectrometer. The level energy of the first excited state, 02+, has been determined at 591(1)keV through direct measurement of conversion electrons. By using the intensity of the observed 02+→01+ transition to the ground state, the feeding of the 02+ state has been determined for the first time, which suggests the 02+ state is the head of the predominantly prolate band. The compositions of the 42+→41+ and 22+→21+ inter-band transitions have been determined, indicating configuration mixing between the bands.
Published: 2024
Full Text: View/download PDF

8. Prognostic factors and overall survival among patients with ovarian cancer in the pre-PARP inhibitor era: the OCRWE-Finland study

Author: Mari Lahelma, Heini Rauhamaa, Riikka-Leena Leskelä, Outi Isomeri, Juhana Idänpään-Heikkilä, Sari Käkelä, Nichola Roebuck, Barbara Mascialino, Sakari Hietanen, Mikko Loukovaara, and Annika Auranen
Subjects: Ovarian cancer, high-grade serous ovarian cancer, real-world evidence, overall survival, neoadjuvant chemotherapy, bevacizumab, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract: Background: Despite recent treatment advances in ovarian cancer (OC), more real-world evidence studies investigating patient outcomes are needed. OCRWE-Finland was an observational cohort study investigating OC outcomes in Finland during the pre-PARP inhibitor era. Patients: Patients were diagnosed with OC between 2014 and 2019 in Finland. This analysis reports baseline characteristics of all patients, patients with high-grade serous OC (HGSOC), and overall survival (OS) for patients with HGSOC. Results: Among 1,711 patients diagnosed with OC, 867 (51%) had HGSOC. The absence versus presence of visible residual disease post-debulking surgery was associated with improved OS for patients at stage III (n = 303; median: NR vs. 43 months; p = 0.005), but not stage IV (n = 118; median: 37 months vs. 40 months; p = 0.96). Bevacizumab treatment at any line at stages III/IV improved OS in the short-term only. Receiving versus not receiving bevacizumab at first-line for patients with visible residual disease post-debulking surgery was associated with improved OS at stage III (median: 48 months vs. 36 months; p = 0.003), but not stage IV (median: 42 months vs. 37 months; p = 0.26). Multivariate Cox regression analyses showed that stage IV at initial diagnosis and the presence of R2 classification post-debulking surgery resulted in poorer OS. Interpretation: In the pre-PARP inhibitor era, the absence versus presence of visible residual disease post-debulking surgery was associated with improved OS in stage III, but not stage IV HGSOC. First-line bevacizumab seemed to be beneficial in patients with stage III HGSOC and visible residual disease.
Published: 2024
Full Text: View/download PDF

9. Real-life treatment patterns and time to next treatment among patients with ovarian cancer in the pre-PARP inhibitor era: the OCRWE-Finland Study

Author: Mari Lahelma, Heini Rauhamaa, Outi Isomeri, Juhana Idänpään-Heikkilä, Sari Käkelä, Nichola Roebuck, Barbara Mascialino, Sakari Hietanen, Mikko Loukovaara, and Annika Auranen
Subjects: High-grade serous ovarian carcinoma, real-world evidence, treatment patterns, time to next treatment, progression-free survival, bevacizumab, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract: Background: As the treatment landscape for advanced ovarian cancer (OC) evolves, it is important to understand patient outcomes in real-world clinical practice. OCRWE-Finland was an observational cohort study investigating OC outcomes, including treatment patterns, time to next treatment 1 (TTNT1), overall survival and healthcare resource utilisation, in Finland during the pre-PARPi era. Materials and methods: Patients included in OCRWE-Finland were diagnosed with OC between 2014 and 2019. Here, we report treatment patterns and TTNT1 outcomes (as a surrogate for progression-free survival) for patients in the high-grade serous ovarian carcinoma (HGSOC) cohort. Results: In OCRWE-Finland, there were 867 patients with HGSOC. Of the 811 patients who received first-line treatment, the most common regimen was surgery and adjuvant chemotherapy (53%), and 227 patients also received first-line bevacizumab. Median TTNT1 among 623 patients with stage III/IV disease was 19 months (95% confidence interval, 18–21 months), with no difference between patients with stage III or IV disease (p = 0.24). The presence versus absence of visible residual disease post-debulking surgery was associated with shorter TTNT1 among patients with stage III tumours (p = 0.031) but showed no impact for stage IV tumours (p = 0.55). First-line versus no first-line bevacizumab was associated with shorter TTNT1 among stages I–IV (p
Published: 2024
Full Text: View/download PDF

10. Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)

Author: Annika Auranen, Matthew A. Powell, Vladyslav Sukhin, Lisa M. Landrum, Graziana Ronzino, Joseph Buscema, Dirk Bauerschlag, Roy Lalisang, David Bender, Lucy Gilbert, Amy Armstrong, Tamar Safra, Nicole Nevadunsky, Alexandra Sebastianelli, Brian Slomovitz, Kari Ring, Robert Coleman, Iwona Podzielinski, Ashley Stuckey, Michael Teneriello, Sarah Gill, Bhavana Pothuri, Lyndsay Willmott, Sudarshan Sharma, Christine Dabrowski, Grace Antony, Shadi Stevens, Mansoor Raza Mirza, and Evelyn Fleming
Subjects: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract: Background: In Part 1 of the phase III RUBY trial (NCT03981796) in patients with primary advanced or recurrent endometrial cancer (EC), dostarlimab plus carboplatin–paclitaxel (CP) significantly improved progression-free survival and overall survival compared with CP alone. Limited safety data have been reported for the combination of immunotherapies plus chemotherapy in this setting. Objectives: The objective of this analysis was to identify the occurrence of treatment-related adverse events (TRAEs) and immune-related adverse events (irAEs) and to describe irAE management in Part 1 of the RUBY trial. Design: RUBY is a phase III, randomized, double-blind, multicenter study of dostarlimab plus CP compared with CP alone in patients with primary advanced or recurrent EC. Methods: Patients were randomized 1:1 to dostarlimab 500 mg, or placebo, plus CP every 3 weeks for 6 cycles, followed by dostarlimab 1000 mg, or placebo, every 6 weeks for up to 3 years. Adverse events (AEs) were assessed according to Common Terminology Criteria for Adverse Events, version 4.03. Results: The safety population included 487 patients who received ⩾1 dose of treatment (241 dostarlimab plus CP; 246 placebo plus CP). Treatment-emergent AEs were experienced by 100% of patients in both arms. TRAEs occurred in 97.9% of the dostarlimab arm and 98.8% of the placebo arm. The most common TRAEs occurred at similar rates between arms and were mostly low grade. IrAEs occurred in 58.5% of patients in the dostarlimab arm and 37.0% of patients in the placebo arm. Dostarlimab- or placebo-related irAEs were reported in 40.7% of patients in the dostarlimab arm and 16.3% of the placebo arm. Conclusion: The safety profile of dostarlimab plus CP was generally consistent with that of the individual components. Dostarlimab plus CP has a favorable benefit–risk profile and is a new standard of care for patients with primary advanced or recurrent EC. Trial registration: NCT03981796.
Published: 2024
Full Text: View/download PDF

11. NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancer

Author: Mirza, M.R., Tandaric, L., Henriksen, J.R., Mäenpää, J., Christensen, R.D., Waldstrøm, M., Lindemann, K., Roed, H., Auranen, A., Akslen, L.A., Thomsen, L.C.V., Lindberg, S.N., Madsen, K., and Bjørge, L.
Published: 2024
Full Text: View/download PDF

12. First observation of excited states in 120La and its impact on the shape evolution in the A ≈ 120 mass region

Author: P.M. Jodidar, C.M. Petrache, B.F. Lv, E.A. Lawrie, A. Astier, S. Guo, K.K. Zheng, K. Auranen, A.D. Briscoe, T. Grahn, P.T. Greenlees, A. Illana, H. Joukainen, R. Julin, J. Louko, M. Luoma, H. Jutila, J. Ojala, J. Pakarinen, A.M. Plaza, P. Rahkila, P. Ruotsalainen, J. Sarén, A. Tolosa-Delgado, J. Uusitalo, G. Zimba, I. Kuti, A. Krakó, C. Andreoiu, D.T. Joss, R.D. Page, E.A. Cederlöf, and A. Ertoprak
Subjects: Nuclear reaction: 58Ni(64Zn,pn)120La, E= 255 MeV, Measured γγγ-coincidences, Eγ, Iγ, Angular correlations, Physics, QC1-999
Abstract: Excited states have been observed for the first time in the very neutron-deficient odd-odd nucleus 57120La63. The observed γ rays have been assigned based on coincidences with lanthanum X rays measured with the JUROGAM 3 array and with A=120 fusion-evaporation residues measured with the MARA separator. The observed γ rays form a rotational band which decays to the ground state via a cascade of four low-energy transitions. Based on the systematic comparisons with the heavier odd-odd La isotopes we assign spin-parity 4+ to the ground state and a πh11/2⊗νh11/2 configuration to the rotational band. The nuclear shape has been investigated by the cranked Nilsson-Strutinsky model. Two quasiparticle plus triaxial rotor model calculations including the np interaction nicely reproduce the spin of the inversion between the even- and odd-spin cascades of E2 transitions, giving credit to the np interaction as an important parameter responsible for the mechanism inducing the inversion. The position of the Fermi levels, in particular for neutrons, also has a strong impact on the observed inversion in the chain of lanthanum nuclei.
Published: 2024
Full Text: View/download PDF

13. TWINGEN: protocol for an observational clinical biobank recall and biomarker cohort study to identify Finnish individuals with high risk of Alzheimer’s disease

Author: Tommi Vasankari, Henri Vähä-Ypyä, Oskari Heikinheimo, Athena Matakidou, Jaakko Kaprio, Eero Vuoksimaa, Ying Wu, Kai Kaarniranta, Peeter Karihtala, Wei Zhou, Caroline Fox, Sanna-Kaisa Herukka, Sarah Smith, Apinya Lertratanakul, Katri Kaukinen, Johannes Kettunen, Minna Männikkö, Eeva Sliz, Markus Perola, Veikko Salomaa, Hilkka Soininen, Ilkka Kalliala, Mika Kähönen, Hao Chen, Andrey Loboda, Laure Morin-Papunen, Terhi Piltonen, Anders Mälarstig, Jason Miller, Jussi Hernesniemi, Henrike Heyne, Sirkku Peltonen, Daniel Gordin, Masahiro Kanai, Benjamin Challis, Juha Sinisalo, David Rice, Fredrik Åberg, Aarno Palotie, Samuli Ripatti, Oili Kaipiainen-Seppänen, Aki Havulinna, Satu Strausz, Tuomo Kiiskinen, Sanni Ruotsalainen, Jukka Koskela, Tuula Palotie, Mark Daly, Howard Jacob, Heiko Runz, Sally John, Robert Plenge, Mark McCarthy, Julie Hunkapiller, Dawn Waterworth, Petri Virolainen, Terhi Kilpi, Jukka Partanen, Anne Pitkäranta, Veli-Matti Kosma, Outi Tuovila, Raimo Pakkanen, Shameek Biswas, Xinli Hu, Johanna Schleutker, Mikko Arvas, Olli Carpen, Reetta Hinttala, Arto Mannermaa, Valtteri Julkunen, Anne Remes, Reetta Kälviäinen, Mikko Hiltunen, Jukka Peltola, Pentti Tienari, Juha Rinne, Adam Ziemann, Jeffrey Waring, Nizar Smaoui, Anne Lehtonen, Susan Eaton, Sanni Lahdenperä, Natalie Bowers, Edmond Teng, Fanli Xu, David Pulford, Martti Färkkilä, Sampsa Pikkarainen, Airi Jussila, Timo Blomster, Mikko Kiviniemi, Markku Voutilainen, Fedik Rahimov, Joseph Maranville, Tim Lu, Kirsi Kalpala, Melissa Miller, Linda McCarthy, Kari Eklund, Antti Palomäki, Pia Isomäki, Laura Pirilä, Johanna Huhtakangas, Marla Hochfeld, Nan Bing, Jorge Esparza Gordillo, Nina Mars, Tarja Laitinen, Margit Pelkonen, Paula Kauppi, Hannu Kankaanranta, Terttu Harju, Hubert Chen, Teemu Niiranen, Kaj Metsärinne, Marja-Riitta Taskinen, Tiinamaija Tuomi, Jari Laukkanen, Audrey Chu, Jaakko Parkkinen, Heikki Joensuu, Tuomo Meretoja, Lauri Aaltonen, Annika Auranen, Päivi Auvinen, Klaus Elenius, Relja Popovic, Bridget Riley-Gillis, Jennifer Schutzman, Heli Lehtonen, Stefan McDonough, Diptee Kulkarni, Terhi Ollila, Hannu Uusitalo, Erich Strauss, Kaisa Tasanen, Laura Huilaja, Katariina Hannula-Jouppi, Teea Salmi, Leena Koulu, David Choy, Anu Jalanko, Risto Kajanne, Mari Kaunisto, Chia-Yen Chen, Robert Yang, Kirsi Auro, Clement Chatelain, Mitja Kurki, Juha Karjalainen, Kimmo Palin, Priit Palta, Susanna Lemmelä, Manuel Rivas, Arto Lehisto, Andrea Ganna, Vincent Llorens, Kati Kristiansson, Kati Hyvärinen, Jarmo Ritari, Katri Pylkäs, Minna Karjalainen, Tuomo Mantere, Eeva Kangasniemi, Sami Heikkinen, Eija Laakkonen, Anu Loukola, Päivi Laiho, Tuuli Sistonen, Essi Kaiharju, Markku Laukkanen, Elina Järvensivu, Sini Lähteenmäki, Lotta Männikkö, Regis Wong, Hannele Mattsson, Tero Hiekkalinna, Kati Donner, Kalle Pärn, Elina Kilpeläinen, Hannele Laivuori, Harri Siirtola, Sirpa Soini, Teijo Kuopio, Ioanna Tachmazidou, Katja Kivinen, Pekka Nieminen, Adam Platt, Sanna Toppila-Salmi, Antti Mäkitie, Elmo Saarentaus, Kristiina Aittomäki, Elisabeth Widen, Marja Vääräsmäki, Erkki Isometsä, Laura Addis, Mika Helminen, Taneli Raivio, Mart Kals, Majd Mouded, Hanna Ollila, Vuokko Anttonen, Tarja Kokkola, Robert Graham, Amanda Elliott, Ali Abbasi, Bridget Riley-Gills, Dirk Paul, Katherine Klinger, Deepak Raipal, Antti Hakanen, Raisa Serpi, Johanna Mäkelä, Mengzhen Liu, Neha Raghavan, Adriana Huertas-Vazquez, Nicole Renaud, Roosa Kallionpää, John Eicher, Minna Raivio, Juulia Partanen, Riitta Lahesmaa, Glenda Lassi, Joanna Betts, Rajashree Mishra, Felix Vaura, Joel Rämö, Mary Pat Reeve, Johanna Mattson, Sauli Vuoti, Esa Pitkänen, Joni A Turunen, Stephanie Loomis, Pirkko Pussinen, Aino Salminen, Tuula Salo, Ulla Palotie, Maria Siponen, Liisa Suominen, Päivi Mäntylä, Ulvi Gursoy, Kirsi Sipilä, Venla Kurra, Laura Kotaniemi-Talonen, Outi Uimari, Taru Tukiainen, Niko Välimäki, Janet Kumar, Juha Mehtonen, Shabbeer Hassan, Pietro Della Briotta Parolo, Mutaamba Maasha, Javier Garcia-Tabuenca, Jiwoo Lee, Kristin Tsuo, Nina Pitkänen, Eero Punkka, Huei-Yi Shen, Mervi Aavikko, L. Elisa Lahtela, Timo P. Sipilä, Awaisa Ghazal, Sami Koskelainen, Teemu Paajanen, Shuang Luo, Javier Gracia-Tabuenca, Tiina Luukkaala, Iida Vähätalo, Marco Hautalahti, Tom Southerington, Paula Iso-Markku, Jaana Suvisaari, Zhihao Ding, Qingqin S Li, Amy Hart, Perttu Terho, Alessandro Porello, Anastasia Kytölä, Antti Aarnisalo, Aoxing Liu, Argyro Bizaki-Vallaskangas, Auli Toivola, Debby Ngo, Dermot Reilly, Ekaterina Khramtsova, Elisa Rahikkala, Eric Green, Eveliina Salminen, Fabiana Farias, George Okafo, Heidi Silven, Heli Salminen-Mankonen, Henna Palin, Iiris Hovatta, Jaakko Tyrmi, Jae-Hoon Sul, Jenni Aittokallio, Jyrki Pitkänen, Karen He, Katriina Aalto-Setälä, Maarit Niinimäki, Malla-Maria Linna, Marc Jung, Margaret G. Ehm, Marianna Niemi, Meijian Guan, Mike Mendelson, Minna Brunfeldt, Natalia Pujol, Nathan Lawless, Oluwaseun Alexander Dada, Rigbe Weldatsadik, Riikka Arffman, Rion Pendergrass, Sahar Mozaffari, Samuel Lessard, Sanna Siltanen, Shanmukha Sampath Padmanabhuni, Simonne Longerich, Susanna Savukoski, Thomas Damm Als, Timo Hiltunen, Tomi P. Mäkelä, Triin Laisk, Tytti Willberg, Varpu Jokimaa, Aija Kyttälä, Toni T Saari, Aino Aaltonen, Sari Aaltonen, Sari Kärkkäinen, Hilkka Liedes, Miina Ollikainen, Teemu Palviainen, Ilona Ruotsalainen, Mia Urjansson, Markus M Forsberg, Jaakko Lähteenmäki, Pia Nyberg, Jani Tikkanen, Mari E. Niemi, and Rodos Rodosthenous
Subjects: Medicine
Abstract: Introduction A better understanding of the earliest stages of Alzheimer’s disease (AD) could expedite the development or administration of treatments. Large population biobanks hold the promise to identify individuals at an elevated risk of AD and related dementias based on health registry information. Here, we establish the protocol for an observational clinical recall and biomarker study called TWINGEN with the aim to identify individuals at high risk of AD by assessing cognition, health and AD-related biomarkers. Suitable candidates were identified and invited to participate in the new study among THL Biobank donors according to TWINGEN study criteria.Methods and analysis A multi-centre study (n=800) to obtain blood-based biomarkers, telephone-administered and web-based memory and cognitive parameters, questionnaire information on lifestyle, health and psychological factors, and accelerometer data for measures of physical activity, sedentary behaviour and sleep. A subcohort is being asked to participate in an in-person neuropsychological assessment (n=200) and wear an Oura ring (n=50). All participants in the TWINGEN study have genome-wide genotyping data and up to 48 years of follow-up data from the population-based older Finnish Twin Cohort (FTC) study of the University of Helsinki. The data collected in TWINGEN will be returned to THL Biobank from where it can later be requested for other biobank studies such as FinnGen that supported TWINGEN.Ethics and dissemination This recall study consists of FTC/THL Biobank/FinnGen participants whose data were acquired in accordance with the Finnish Biobank Act. The recruitment protocols followed the biobank protocols approved by Finnish Medicines Agency. The TWINGEN study plan was approved by the Ethics Committee of Hospital District of Helsinki and Uusimaa (number 16831/2022). THL Biobank approved the research plan with the permission no: THLBB2022_83.
Published: 2024
Full Text: View/download PDF

14. Rare PMP22 variants in mild to severe neuropathy uncorrelated to plasma GDF15 or neurofilament light

Author: Palu, Edouard, Järvilehto, Julius, Pennonen, Jana, Huber, Nadine, Herukka, Sanna-Kaisa, Haapasalo, Annakaisa, Isohanni, Pirjo, Tyynismaa, Henna, Auranen, Mari, and Ylikallio, Emil
Published: 2023
Full Text: View/download PDF

15. Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study

Author: Graybill, Whitney S, Pardo Búrdalo, Beatriz, O’Malley, David M, Vergote, Ignace, Monk, Bradley J, Auranen, Annika, Copeland, Larry J, Sabbatini, Roberto, Herzog, Thomas J, Follana, Philippe, Pothuri, Bhavana, Braicu, Elena Ioana, McCormick, Colleen, Yubero, Alfonso, Moore, Richard G, Vuylsteke, Peter, Raaschou-Jensen, Nicoline, York, Whitney, Hartman, John, González-Martín, Antonio, and Stockman, Liz
Published: 2024
Full Text: View/download PDF

16. Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank

Author: Palotie, Aarno, Daly, Mark, Riley-Gills, Bridget, Jacob, Howard, Viollet, Coralie, Petrovski, Slavé, Chen, Chia-Yen, John, Sally, Okafo, George, Plenge, Robert, Maranville, Joseph, McCarthy, Mark, Pendergrass, Rion, Ehm, Margaret G., Auro, Kirsi, Longerich, Simonne, Mälarstig, Anders, Vlahiotis, Anna, Klinger, Katherine, Chatelain, Clement, Gossel, Matthias, Estrada, Karol, Graham, Robert, Waterworth, Dawn, O´Donnell, Chris, Renaud, Nicole, Mäkelä, Tomi P., Kaprio, Jaakko, Ruddock, Minna, Virolainen, Petri, Hakanen, Antti, Kilpi, Terhi, Perola, Markus, Partanen, Jukka, Raivio, Taneli, Tikkanen, Jani, Serpi, Raisa, Kristiansson, Kati, Kosma, Veli-Matti, Laukkanen, Jari, Hautalahti, Marco, Tuovila, Outi, Waring, Jeffrey, Riley-Gillis, Bridget, Rahimov, Fedik, Tachmazidou, Ioanna, Ding, Zhihao, Jung, Marc, Tuoken, Hanati, Biswas, Shameek, Pulford, David, Raghavan, Neha, Huertas-Vazquez, Adriana, Sul, Jae-Hoon, Hu, Xinli, Hedman, Åsa, Obeidat, Ma´en, Chung, Jonathan, Zierer, Jonas, Niemi, Mari, Ripatti, Samuli, Schleutker, Johanna, Arvas, Mikko, Carpén, Olli, Hinttala, Reetta, Kettunen, Johannes, Mannermaa, Arto, Aalto-Setälä, Katriina, Kähönen, Mika, Mäkelä, Johanna, Kälviäinen, Reetta, Julkunen, Valtteri, Soininen, Hilkka, Remes, Anne, Hiltunen, Mikko, Peltola, Jukka, Raivio, Minna, Tienari, Pentti, Rinne, Juha, Kallionpää, Roosa, Partanen, Juulia, Ziemann, Adam, Smaoui, Nizar, Lehtonen, Anne, Eaton, Susan, Runz, Heiko, Lahdenperä, Sanni, Bowers, Natalie, Teng, Edmond, Xu, Fanli, Addis, Laura, Eicher, John, Li, Qingqin S., He, Karen, Khramtsova, Ekaterina, Färkkilä, Martti, Koskela, Jukka, Pikkarainen, Sampsa, Jussila, Airi, Kaukinen, Katri, Blomster, Timo, Kiviniemi, Mikko, Voutilainen, Markku, Lu, Tim, McCarthy, Linda, Hart, Amy, Guan, Meijian, Miller, Jason, Kalpala, Kirsi, Miller, Melissa, Eklund, Kari, Palomäki, Antti, Isomäki, Pia, Pirilä, Laura, Kaipiainen-Seppänen, Oili, Huhtakangas, Johanna, Mars, Nina, Lertratanakul, Apinya, Hochfeld, Marla, Gordillo, Jorge Esparza, Farias, Fabiana, Bing, Nan, Laitinen, Tarja, Pelkonen, Margit, Kauppi, Paula, Kankaanranta, Hannu, Harju, Terttu, Lahesmaa, Riitta, Chen, Hubert, Betts, Joanna, Mishra, Rajashree, Mouded, Majd, Ngo, Debby, Niiranen, Teemu, Vaura, Felix, Salomaa, Veikko, Metsärinne, Kaj, Aittokallio, Jenni, Hernesniemi, Jussi, Gordin, Daniel, Sinisalo, Juha, Taskinen, Marja-Riitta, Tuomi, Tiinamaija, Hiltunen, Timo, Elliott, Amanda, Reeve, Mary Pat, Ruotsalainen, Sanni, Paul, Dirk, Chu, Audrey, Reilly, Dermot, Mendelson, Mike, Parkkinen, Jaakko, Meretoja, Tuomo, Joensuu, Heikki, Mattson, Johanna, Salminen, Eveliina, Auranen, Annika, Karihtala, Peeter, Auvinen, Päivi, Elenius, Klaus, Pitkänen, Esa, Popovic, Relja, Fabre, Margarete, Schutzman, Jennifer, Kulkarni, Diptee, Porello, Alessandro, Loboda, Andrey, Lehtonen, Heli, McDonough, Stefan, Vuoti, Sauli, Kaarniranta, Kai, Turunen, Joni A., Ollila, Terhi, Uusitalo, Hannu, Karjalainen, Juha, Liu, Mengzhen, Loomis, Stephanie, Strauss, Erich, Chen, Hao, Tasanen, Kaisa, Huilaja, Laura, Hannula-Jouppi, Katariina, Salmi, Teea, Peltonen, Sirkku, Koulu, Leena, Choy, David, Wu, Ying, Pussinen, Pirkko, Salminen, Aino, Salo, Tuula, Rice, David, Nieminen, Pekka, Palotie, Ulla, Siponen, Maria, Suominen, Liisa, Mäntylä, Päivi, Gursoy, Ulvi, Anttonen, Vuokko, Sipilä, Kirsi, Laivuori, Hannele, Kurra, Venla, Kotaniemi-Talonen, Laura, Heikinheimo, Oskari, Kalliala, Ilkka, Aaltonen, Lauri, Jokimaa, Varpu, Vääräsmäki, Marja, Uimari, Outi, Morin-Papunen, Laure, Niinimäki, Maarit, Piltonen, Terhi, Kivinen, Katja, Widen, Elisabeth, Tukiainen, Taru, Välimäki, Niko, Laakkonen, Eija, Tyrmi, Jaakko, Silven, Heidi, Sliz, Eeva, Arffman, Riikka, Savukoski, Susanna, Laisk, Triin, Pujol, Natalia, Kumar, Janet, Hovatta, Iiris, Isometsä, Erkki, Ollila, Hanna, Suvisaari, Jaana, Mäkitie, Antti, Bizaki-Vallaskangas, Argyro, Toppila-Salmi, Sanna, Willberg, Tytti, Saarentaus, Elmo, Aarnisalo, Antti, Rahikkala, Elisa, Aittomäki, Kristiina, Åberg, Fredrik, Kurki, Mitja, Havulinna, Aki, Mehtonen, Juha, Palta, Priit, Hassan, Shabbeer, Della Briotta Parolo, Pietro, Zhou, Wei, Maasha, Mutaamba, Lemmelä, Susanna, Rivas, Manuel, Liu, Aoxing, Lehisto, Arto, Ganna, Andrea, Llorens, Vincent, Heyne, Henrike, Rämö, Joel, Rodosthenous, Rodos, Strausz, Satu, Palotie, Tuula, Palin, Kimmo, Garcia-Tabuenca, Javier, Siirtola, Harri, Kiiskinen, Tuomo, Lee, Jiwoo, Tsuo, Kristin, Hyvärinen, Kati, Ritari, Jarmo, Pylkäs, Katri, Karjalainen, Minna, Mantere, Tuomo, Kangasniemi, Eeva, Heikkinen, Sami, Pitkänen, Nina, Lessard, Samuel, Chatelain, Clément, Kallio, Lila, Wahlfors, Tiina, Punkka, Eero, Siltanen, Sanna, Kuopio, Teijo, Jalanko, Anu, Shen, Huei-Yi, Kajanne, Risto, Aavikko, Mervi, Cooper, Helen, Öller, Denise, Leinonen, Rasko, Palin, Henna, Linna, Malla-Maria, Kanai, Masahiro, Zheng, Zhili, Lahtela, L. Elisa, Kaunisto, Mari, Kilpeläinen, Elina, Sipilä, Timo P., Dada, Oluwaseun Alexander, Ghazal, Awaisa, Kytölä, Anastasia, Weldatsadik, Rigbe, Donner, Kati, Loukola, Anu, Laiho, Päivi, Sistonen, Tuuli, Kaiharju, Essi, Laukkanen, Markku, Järvensivu, Elina, Lähteenmäki, Sini, Männikkö, Lotta, Wong, Regis, Toivola, Auli, Brunfeldt, Minna, Mattsson, Hannele, Koskelainen, Sami, Hiekkalinna, Tero, Paajanen, Teemu, Luo, Shuang, Padmanabhuni, Shanmukha Sampath, Niemi, Marianna, Gracia-Tabuenca, Javier, Helminen, Mika, Luukkaala, Tiina, Vähätalo, Iida, Tammerluoto, Jyrki, Smith, Sarah, Southerington, Tom, Lehto, Petri, Ryu, Justine, Rämö, Joel T., Jurgens, Sean J., Sanna-Cherchi, Simone, Bauer, Kenneth A., Haj, Amelia, Choi, Seung Hoan, Ellinor, Patrick T., and Bendapudi, Pavan K.
Published: 2024
Full Text: View/download PDF

17. High-Resolution Genotyping of Formalin-Fixed Tissue Accurately Estimates Polygenic Risk Scores in Human Diseases

Author: Palotie, Aarno, Daly, Mark, Riley-Gills, Bridget, Jacob, Howard, Paul, Dirk, Petrovski, Slavé, Runz, Heiko, John, Sally, Okafo, George, Lawless, Nathan, Salminen-Mankonen, Heli, Plenge, Robert, Maranville, Joseph, McCarthy, Mark, Ehm, Margaret G., Auro, Kirsi, Longerich, Simonne, Mälarstig, Anders, Klinger, Katherine, Chatelain, Clement, Gossel, Matthias, Estrada, Karol, Graham, Robert, Yang, Robert, ODonnell, Chris, Mäkelä, Tomi P., Kaprio, Jaakko, Virolainen, Petri, Hakanen, Antti, Kilpi, Terhi, Perola, Markus, Partanen, Jukka, Pitkäranta, Anne, Raivio, Taneli, Tikkanen, Jani, Serpi, Raisa, Laitinen, Tarja, Kosma, Veli-Matti, Laukkanen, Jari, Hautalahti, Marco, Tuovila, Outi, Pakkanen, Raimo, Waring, Jeffrey, Riley-Gillis, Bridget, Rahimov, Fedik, Tachmazidou, Ioanna, Chen, Chia-Yen, Ding, Zhihao, Jung, Marc, Biswas, Shameek, Pendergrass, Rion, Pulford, David, Raghavan, Neha, Huertas-Vazquez, Adriana, Sul, Jae-Hoon, Hu, Xinli, Hedman, Åsa, Rivas, Manuel, Waterworth, Dawn, Renaud, Nicole, Obeidat, Maen, Ripatti, Samuli, Schleutker, Johanna, Arvas, Mikko, Carpén, Olli, Hinttala, Reetta, Kettunen, Johannes, Mannermaa, Arto, Aalto-Setälä, Katriina, Kähönen, Mika, Mäkelä, Johanna, Kälviäinen, Reetta, Julkunen, Valtteri, Soininen, Hilkka, Remes, Anne, Hiltunen, Mikko, Peltola, Jukka, Raivio, Minna, Tienari, Pentti, Rinne, Juha, Kallionpää, Roosa, Partanen, Juulia, Abbasi, Ali, Ziemann, Adam, Smaoui, Nizar, Lehtonen, Anne, Eaton, Susan, Lahdenperä, Sanni, Bowers, Natalie, Teng, Edmond, Xu, Fanli, Addis, Laura, Eicher, John, Li, Qingqin S., He, Karen, Khramtsova, Ekaterina, Färkkilä, Martti, Koskela, Jukka, Pikkarainen, Sampsa, Jussila, Airi, Kaukinen, Katri, Blomster, Timo, Kiviniemi, Mikko, Voutilainen, Markku, Lu, Tim, McCarthy, Linda, Hart, Amy, Guan, Meijian, Miller, Jason, Kalpala, Kirsi, Miller, Melissa, Eklund, Kari, Palomäki, Antti, Isomäki, Pia, Pirilä, Laura, Kaipiainen-Seppänen, Oili, Huhtakangas, Johanna, Mars, Nina, Lertratanakul, Apinya, Viollet, Coralie, Hochfeld, Marla, Gordillo, Jorge Esparza, Farias, Fabiana, Bing, Nan, Pelkonen, Margit, Kauppi, Paula, Kankaanranta, Hannu, Harju, Terttu, Lahesmaa, Riitta, Chen, Hubert, Betts, Joanna, Mishra, Rajashree, Mouded, Majd, Ngo, Debby, Niiranen, Teemu, Vaura, Felix, Salomaa, Veikko, Metsärinne, Kaj, Aittokallio, Jenni, Hernesniemi, Jussi, Gordin, Daniel, Sinisalo, Juha, Taskinen, Marja-Riitta, Tuomi, Tiinamaija, Hiltunen, Timo, Elliott, Amanda, Reeve, Mary Pat, Ruotsalainen, Sanni, Chu, Audrey, Reilly, Dermot, Mendelson, Mike, Parkkinen, Jaakko, Meretoja, Tuomo, Joensuu, Heikki, Mattson, Johanna, Salminen, Eveliina, Auranen, Annika, Karihtala, Peeter, Auvinen, Päivi, Elenius, Klaus, Pitkänen, Esa, Popovic, Relja, Fabre, Margarete, Schutzman, Jennifer, Kulkarni, Diptee, Porello, Alessandro, Loboda, Andrey, Lehtonen, Heli, McDonough, Stefan, Vuoti, Sauli, Kaarniranta, Kai, Turunen, Joni A., Ollila, Terhi, Uusitalo, Hannu, Karjalainen, Juha, Liu, Mengzhen, Loomis, Stephanie, Strauss, Erich, Chen, Hao, Tasanen, Kaisa, Huilaja, Laura, Hannula-Jouppi, Katariina, Salmi, Teea, Peltonen, Sirkku, Koulu, Leena, Choy, David, Wu, Ying, Pussinen, Pirkko, Salminen, Aino, Salo, Tuula, Rice, David, Nieminen, Pekka, Palotie, Ulla, Siponen, Maria, Suominen, Liisa, Mäntylä, Päivi, Gursoy, Ulvi, Anttonen, Vuokko, Sipilä, Kirsi, Laivuori, Hannele, Kurra, Venla, Kotaniemi-Talonen, Laura, Heikinheimo, Oskari, Kalliala, Ilkka, Aaltonen, Lauri, Jokimaa, Varpu, Vääräsmäki, Marja, Uimari, Outi, Morin-Papunen, Laure, Niinimäki, Maarit, Piltonen, Terhi, Kivinen, Katja, Widen, Elisabeth, Tukiainen, Taru, Välimäki, Niko, Laakkonen, Eija, Tyrmi, Jaakko, Silven, Heidi, Sliz, Eeva, Arffman, Riikka, Savukoski, Susanna, Laisk, Triin, Pujol, Natalia, Kumar, Janet, Hovatta, Iiris, Isometsä, Erkki, Ollila, Hanna, Suvisaari, Jaana, Als, Thomas Damm, Mäkitie, Antti, Bizaki-Vallaskangas, Argyro, Toppila-Salmi, Sanna, Willberg, Tytti, Saarentaus, Elmo, Aarnisalo, Antti, Rahikkala, Elisa, Aittomäki, Kristiina, Åberg, Fredrik, Kurki, Mitja, Havulinna, Aki, Mehtonen, Juha, Palta, Priit, Hassan, Shabbeer, Della Briotta Parolo, Pietro, Zhou, Wei, Maasha, Mutaamba, Lemmelä, Susanna, Liu, Aoxing, Lehisto, Arto, Ganna, Andrea, Llorens, Vincent, Heyne, Henrike, Rämö, Joel, Rodosthenous, Rodos, Strausz, Satu, Palotie, Tuula, Palin, Kimmo, Garcia-Tabuenca, Javier, Siirtola, Harri, Kiiskinen, Tuomo, Lee, Jiwoo, Tsuo, Kristin, Kristiansson, Kati, Hyvärinen, Kati, Ritari, Jarmo, Pylkäs, Katri, Karjalainen, Minna, Mantere, Tuomo, Kangasniemi, Eeva, Heikkinen, Sami, Pitkänen, Nina, Lessard, Samuel, Chatelain, Clément, Kallio, Lila, Wahlfors, Tiina, Punkka, Eero, Siltanen, Sanna, Kuopio, Teijo, Jalanko, Anu, Shen, Huei-Yi, Kajanne, Risto, Aavikko, Mervi, Cooper, Helen, Öller, Denise, Leinonen, Rasko, Palin, Henna, Linna, Malla-Maria, Kanai, Masahiro, Zheng, Zhili, Lahtela, L. Elisa, Kaunisto, Mari, Kilpeläinen, Elina, Sipilä, Timo P., Dada, Oluwaseun Alexander, Ghazal, Awaisa, Kytölä, Anastasia, Weldatsadik, Rigbe, Donner, Kati, Loukola, Anu, Laiho, Päivi, Sistonen, Tuuli, Kaiharju, Essi, Laukkanen, Markku, Järvensivu, Elina, Lähteenmäki, Sini, Männikkö, Lotta, Wong, Regis, Toivola, Auli, Brunfeldt, Minna, Mattsson, Hannele, Koskelainen, Sami, Hiekkalinna, Tero, Paajanen, Teemu, Pärn, Kalle, Kals, Mart, Luo, Shuang, Padmanabhuni, Shanmukha Sampath, Niemi, Marianna, Gracia-Tabuenca, Javier, Helminen, Mika, Luukkaala, Tiina, Vähätalo, Iida, Tammerluoto, Jyrki, Smith, Sarah, Southerington, Tom, Lehto, Petri, Youssef, Omar, Zidi-Mouaffak, Yossra H.S., and Tamlander, Max
Published: 2024
Full Text: View/download PDF

18. A national precision cancer medicine implementation initiative for Finland

Author: Katriina J. Jalkanen, Erika Alanne, Sanna Iivanainen, Okko-Sakari Kääriäinen, Minna Tanner, Annika Auranen, Jussi Koivunen, Timo K. Nykopp, Pia Vihinen, and Mika Mustonen
Subjects: FINPROVE, DRUP-Like-Trials, Precision Medicine, PRIME-ROSE, PCM4EU, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Published: 2024
Full Text: View/download PDF

19. Shape Coexistence at Zero Spin in 64Ni Driven by the Monopole Tensor Interaction

Author: Mărginean, N., Little, D., Tsunoda, Y., Leoni, S., Janssens, R. V. F., Fornal, B., Otsuka, T., Michelagnoli, C., Stan, L., Crespi, F. C. L., Costache, C., Lica, R., Sferrazza, M., Turturica, A., Ayangeakaa, A. D., Auranen, K., Barani, M., Bender, P. C., Bottoni, S., Boromiza, M., Bracco, A., Călinescu, S., Campbell, C. M., Carpenter, M. P., Chowdhury, P., Ciemała, M., Cieplicka-Orynczak, N., Cline, D., Clisu, C., Crawford, H. L., Dinescu, I. E., Filipescu, D., Florea, N., Forney, A. M., Fracassetti, S., Gade, A., Gheorghe, I., Hayes, A. B., Harca, I., Henderson, J., Ionescu, A., Iskra, Ł. W., Jentschel, M., Kandzia, F., Kim, Y. H., Kondev, F. G., Korschinek, G., Köster, U., Krishichayan, Krzysiek, M., Lauritsen, T., Li, J., Mărginean, R., Maugeri, E. A., Mihai, C., Mihai, R. E., Mitu, A., Mutti, P., Negret, A., Niţă, C. R., Olăcel, A., Oprea, A., Pascu, S., Petrone, C., Porzio, C., Rhodes, D., Seweryniak, D., Schumann, D., Sotty, C., Stolze, S. M., Şuvăilă, R., Toma, S., Ujeniuc, S., Walters, W. B., Wu, C. Y., Wu, J., Zhu, S., and Ziliani, S.
Subjects: Nuclear Experiment, Nuclear Theory
Abstract: The low-spin structure of the semimagic 64Ni nucleus has been considerably expanded: combining four experiments, several 0+ and 2+ excited states were identified below 4.5 MeV, and their properties established. The Monte Carlo shell model accounts for the results and unveils an unexpectedly complex landscape of coexisting shapes: a prolate 0+ excitation is located at a surprisingly high energy (3463 keV), with a collective 2+ state 286 keV above it, the first such observation in Ni isotopes. The evolution in excitation energy of the prolate minimum across the neutron N = 40 subshell gap highlights the impact of the monopole interaction and its variation in strength with N.
Published: 2020
Full Text: View/download PDF

20. Efficacy and effectiveness of case isolation and quarantine during a growing phase of the COVID-19 epidemic in Finland

Author: Auranen, Kari, Shubin, Mikhail, Erra, Elina, Isosomppi, Sanna, Kontto, Jukka, Leino, Tuija, and Lukkarinen, Timo
Published: 2023
Full Text: View/download PDF

21. Octupole correlations in the N = Z + 2 = 56 110Xe nucleus

Author: A. Illana, R.M. Pérez-Vidal, D. Stramaccioni, J.J. Valiente-Dobón, T.R. Rodriguez, L.M. Robledo, A. Poves, K. Auranen, O. Beliuskina, C. Delafosse, T. Eronen, Z. Ge, S. Geldhof, W. Gins, T. Grahn, P.T. Greenlees, H. Joukainen, R. Julin, H. Jutila, A. Kankainen, M. Leino, J. Louko, M. Luoma, D. Nesterenko, J. Ojala, J. Pakarinen, P. Rahkila, P. Ruotsalainen, M. Sandzelius, J. Sarén, J. Uusitalo, and G.L. Zimba
Subjects: Octupole deformations, 110Xe, N=Z=56 region, Fusion evaporation reactions, Physics, QC1-999
Abstract: This letter reports on the first observation of an octupole band in the neutron-deficient (N=Z+2) nucleus 110Xe. The 110Xe nuclei were produced via the 54Fe(58Ni,2n) fusion-evaporation reaction. The emitted γ rays were detected using the jurogam 3 γ-ray spectrometer, while the fusion-evaporation residues were separated with the MARA separator at the Accelerator Laboratory of the University of Jyväskylä, Finland. The experimental observation of the low-lying 3− and 5− states and inter-band E1 transitions between the ground-state band and the octupole band proves the importance of octupole correlations in this region. These new experimental data combined with theoretical calculations using the symmetry-conserving configuration-mixing method, based on a Gogny energy density functional, have been interpreted as an evidence of enhanced octupole correlations in neutron-deficient xenon isotopes.
Published: 2024
Full Text: View/download PDF

22. Isospin symmetry in the T = 1,A = 62 triplet

Author: K. Wimmer, P. Ruotsalainen, S.M. Lenzi, A. Poves, T. Hüyük, F. Browne, P. Doornenbal, T. Koiwai, T. Arici, K. Auranen, M.A. Bentley, M.L. Cortés, C. Delafosse, T. Eronen, Z. Ge, T. Grahn, P.T. Greenlees, A. Illana, N. Imai, H. Joukainen, R. Julin, A. Jungclaus, H. Jutila, A. Kankainen, N. Kitamura, B. Longfellow, J. Louko, R. Lozeva, M. Luoma, B. Mauss, D.R. Napoli, M. Niikura, J. Ojala, J. Pakarinen, X. Pereira-Lopez, P. Rahkila, F. Recchia, M. Sandzelius, J. Sarén, R. Taniuchi, H. Tann, S. Uthayakumaar, J. Uusitalo, V. Vaquero, R. Wadsworth, G. Zimba, and R. Yajzey
Subjects: Physics, QC1-999
Abstract: Excited states in the Tz=0,−1 nuclei 62Ga and 62Ge were populated in direct reactions of relativistic radioactive ion beams at the RIBF. Coincident γ rays were measured with the DALI2+ array and uniquely assigned to the A=62 isobars. In addition, 62Ge was also studied independently at JYFL-ACCLAB using the 24Mg(40Ca,2n)62Ge fusion-evaporation reaction. The first excited T=1,Jπ=2+ states in 62Ga and 62Ge were identified at 979(1) and 965(1) keV, respectively, resolving discrepant interpretations in the literature. States beyond the first 2+ state in 62Ge were also identified for the first time in the present work. The results are compared with shell-model calculations in the fp model space. Mirror and triplet energy differences are analyzed in terms of individual charge-symmetry and charge-independence breaking contributions. The MED results confirm the shrinkage of the p-orbits' radii when they are occupied by at least one nucleon on average.
Published: 2023
Full Text: View/download PDF

23. Decay spectroscopy at the two-proton drip line: Radioactivity of the new nuclides 160Os and 156W

Author: A.D. Briscoe, R.D. Page, J. Uusitalo, D.T. Joss, M.A.M. AlAqeel, B. Alayed, B. Andel, S. Antalic, K. Auranen, H. Ayatollahzadeh, H. Badran, L. Barber, G. Beeton, M. Birova, V. Bogdanoff, R.M. Clark, J.G. Cubiss, D.M. Cullen, J. Deary, U. Forsberg, T. Grahn, P.T. Greenlees, J.B. Hilton, A. Illana, H. Joukainen, D.S. Judson, R. Julin, H. Jutila, J.M. Keatings, M. Labiche, M. Leino, M.C. Lewis, J. Louko, M. Luoma, I. Martel, A. McCarter, P.P. McKee, P. Mosat, S.N. Nathaniel, O. Neuvonen, D. O'Donnell, J. Ojala, C.A.A. Page, A.M. Plaza, J. Pakarinen, P. Papadakis, E. Parr, J. Partanen, P. Rahkila, P. Ruotsalainen, M. Sandzelius, J. Sarén, B. Saygi, J. Smallcombe, J.F. Smith, J. Sorri, C.M. Sullivan, S. Szwec, H. Tann, A. Tolosa-Delgado, E. Uusikylä, M. Venhart, L.J. Waring, and G. Zimba
Subjects: Physics, QC1-999
Abstract: The radioactivity of 76160Os84 and 74156W82 that lie at the two-proton drip line has been measured in an experiment performed at the Accelerator Laboratory of the University of Jyväskylä. The 160Os nuclei were produced using fusion-evaporation reactions induced by a beam of 310 MeV 58Ni ions bombarding a 106Cd target. The 160Os ions were separated in flight using the recoil separator MARA and implanted into a double-sided silicon strip detector, which was used to measure their decays. The α decays of the ground state of 160Os (Eα = 7092(15) keV, t1/2 = 97−32+97 μs) and its isomeric state (Eα = 8890(10) keV, t1/2 = 41−9+15 μs) were measured, allowing the excitation energy of the isomer to be determined as 1844(18) keV. These α-decay properties and the excitation energy of the isomer are compared with systematics. The α decays were correlated with subsequent decays to investigate the β decays of the ground state of 156W, revealing that unlike its isotones, both low-lying isomers were populated in its daughter nuclide, 156Ta. An improved value for the half-life of the proton-decaying high-spin isomeric state in 73156Ta83 of 333−22+25 ms was obtained in a separate experiment using the same experimental systems with a 102Pd target. This result was employed to improve the precision of the half-life determined for 156W, which was measured as 157−34+57 ms.
Published: 2023
Full Text: View/download PDF

24. PErsonalized TReatment for Endometrial Carcinoma (PETREC): study design and methods of a prospective Finnish multicenter trial

Author: Loukovaara, Mikko, Bützow, Ralf, Staff, Synnöve, Mäenpää, Minna, Faltinová, Mária, Lassus, Heini, Veijalainen, Olga, Grönvall, Maiju, Vaalavirta, Leila, Kuikka, Elina, Haataja, Marjut, Urpilainen, Elina, Simojoki, Marja, Anttila, Maarit, and Auranen, Annika
Published: 2023
Full Text: View/download PDF

25. The public health impact of poor sleep on severe COVID-19, influenza and upper respiratory infections

Author: Palotie, Aarno, Daly, Mark, Riley-Gills, Bridget, Jacob, Howard, Paul, Dirk, Petrovski, Slavé, Runz, Heiko, John, Sally, Okafo, George, Lawless, Nathan, Salminen-Mankonen, Heli, Plenge, Robert, Maranville, Joseph, McCarthy, Mark, Ehm, Margaret G., Auro, Kirsi, Longerich, Simonne, Mälarstig, Anders, Klinger, Katherine, Chatelain, Clement, Gossel, Matthias, Estrada, Karol, Graham, Robert, Yang, Robert, O´Donnell, Chris, Mäkelä, Tomi P., Kaprio, Jaakko, Virolainen, Petri, Hakanen, Antti, Kilpi, Terhi, Perola, Markus, Partanen, Jukka, Pitkäranta, Anne, Raivio, Taneli, Tikkanen, Jani, Serpi, Raisa, Laitinen, Tarja, Kosma, Veli-Matti, Laukkanen, Jari, Hautalahti, Marco, Tuovila, Outi, Pakkanen, Raimo, Waring, Jeffrey, Riley-Gillis, Bridget, Rahimov, Fedik, Tachmazidou, Ioanna, Chen, Chia-Yen, Ding, Zhihao, Jung, Marc, Biswas, Shameek, Pendergrass, Rion, Pulford, David, Raghavan, Neha, Huertas-Vazquez, Adriana, Sul, Jae-Hoon, Hu, Xinli, Hedman, Åsa, Rivas, Manuel, Waterworth, Dawn, Renaud, Nicole, Obeidat, Ma´en, Ripatti, Samuli, Schleutker, Johanna, Arvas, Mikko, Carpén, Olli, Hinttala, Reetta, Kettunen, Johannes, Mannermaa, Arto, Aalto-Setälä, Katriina, Kähönen, Mika, Mäkelä, Johanna, Kälviäinen, Reetta, Julkunen, Valtteri, Soininen, Hilkka, Remes, Anne, Hiltunen, Mikko, Peltola, Jukka, Raivio, Minna, Tienari, Pentti, Rinne, Juha, Kallionpää, Roosa, Partanen, Juulia, Abbasi, Ali, Ziemann, Adam, Smaoui, Nizar, Lehtonen, Anne, Eaton, Susan, Lahdenperä, Sanni, Bowers, Natalie, Teng, Edmond, Xu, Fanli, Addis, Laura, Eicher, John, Li, Qingqin S., He, Karen, Khramtsova, Ekaterina, Färkkilä, Martti, Koskela, Jukka, Pikkarainen, Sampsa, Jussila, Airi, Kaukinen, Katri, Blomster, Timo, Kiviniemi, Mikko, Voutilainen, Markku, Lu, Tim, McCarthy, Linda, Hart, Amy, Guan, Meijian, Miller, Jason, Kalpala, Kirsi, Miller, Melissa, Eklund, Kari, Palomäki, Antti, Isomäki, Pia, Pirilä, Laura, Kaipiainen-Seppänen, Oili, Huhtakangas, Johanna, Mars, Nina, Lertratanakul, Apinya, Viollet, Coralie, Hochfeld, Marla, Gordillo, Jorge Esparza, Farias, Fabiana, Bing, Nan, Pelkonen, Margit, Kauppi, Paula, Kankaanranta, Hannu, Harju, Terttu, Lahesmaa, Riitta, Chen, Hubert, Betts, Joanna, Mishra, Rajashree, Mouded, Majd, Ngo, Debby, Niiranen, Teemu, Vaura, Felix, Salomaa, Veikko, Metsärinne, Kaj, Aittokallio, Jenni, Hernesniemi, Jussi, Gordin, Daniel, Sinisalo, Juha, Taskinen, Marja-Riitta, Tuomi, Tiinamaija, Hiltunen, Timo, Elliott, Amanda, Reeve, Mary Pat, Ruotsalainen, Sanni, Chu, Audrey, Reilly, Dermot, Mendelson, Mike, Parkkinen, Jaakko, Meretoja, Tuomo, Joensuu, Heikki, Mattson, Johanna, Salminen, Eveliina, Auranen, Annika, Karihtala, Peeter, Auvinen, Päivi, Elenius, Klaus, Pitkänen, Esa, Popovic, Relja, Fabre, Margarete, Schutzman, Jennifer, Kulkarni, Diptee, Porello, Alessandro, Loboda, Andrey, Lehtonen, Heli, McDonough, Stefan, Vuoti, Sauli, Kaarniranta, Kai, Turunen, Joni A., Ollila, Terhi, Uusitalo, Hannu, Karjalainen, Juha, Liu, Mengzhen, Loomis, Stephanie, Strauss, Erich, Chen, Hao, Tasanen, Kaisa, Huilaja, Laura, Hannula-Jouppi, Katariina, Salmi, Teea, Peltonen, Sirkku, Koulu, Leena, Choy, David, Wu, Ying, Pussinen, Pirkko, Salminen, Aino, Salo, Tuula, Rice, David, Nieminen, Pekka, Palotie, Ulla, Siponen, Maria, Suominen, Liisa, Mäntylä, Päivi, Gursoy, Ulvi, Anttonen, Vuokko, Sipilä, Kirsi, Laivuori, Hannele, Kurra, Venla, Kotaniemi-Talonen, Laura, Heikinheimo, Oskari, Kalliala, Ilkka, Aaltonen, Lauri, Jokimaa, Varpu, Vääräsmäki, Marja, Uimari, Outi, Morin-Papunen, Laure, Niinimäki, Maarit, Piltonen, Terhi, Kivinen, Katja, Widen, Elisabeth, Tukiainen, Taru, Välimäki, Niko, Laakkonen, Eija, Tyrmi, Jaakko, Silven, Heidi, Sliz, Eeva, Arffman, Riikka, Savukoski, Susanna, Laisk, Triin, Pujol, Natalia, Kumar, Janet, Hovatta, Iiris, Isometsä, Erkki, Ollila, Hanna, Suvisaari, Jaana, Als, Thomas Damm, Mäkitie, Antti, Bizaki-Vallaskangas, Argyro, Toppila-Salmi, Sanna, Willberg, Tytti, Saarentaus, Elmo, Aarnisalo, Antti, Rahikkala, Elisa, Aittomäki, Kristiina, Åberg, Fredrik, Kurki, Mitja, Havulinna, Aki, Mehtonen, Juha, Palta, Priit, Hassan, Shabbeer, Della Briotta Parolo, Pietro, Zhou, Wei, Maasha, Mutaamba, Lemmelä, Susanna, Liu, Aoxing, Lehisto, Arto, Ganna, Andrea, Llorens, Vincent, Heyne, Henrike, Rämö, Joel, Rodosthenous, Rodos, Strausz, Satu, Palotie, Tuula, Palin, Kimmo, Garcia-Tabuenca, Javier, Siirtola, Harri, Kiiskinen, Tuomo, Lee, Jiwoo, Tsuo, Kristin, Kristiansson, Kati, Hyvärinen, Kati, Ritari, Jarmo, Pylkäs, Katri, Karjalainen, Minna, Mantere, Tuomo, Kangasniemi, Eeva, Heikkinen, Sami, Pitkänen, Nina, Lessard, Samuel, Chatelain, Clément, Kallio, Lila, Wahlfors, Tiina, Punkka, Eero, Siltanen, Sanna, Kuopio, Teijo, Jalanko, Anu, Shen, Huei-Yi, Kajanne, Risto, Aavikko, Mervi, Leinonen, Rasko, Palin, Henna, Linna, Malla-Maria, Kanai, Masahiro, Zheng, Zhili, Lahtela, L. Elisa, Kaunisto, Mari, Kilpeläinen, Elina, Sipilä, Timo P., Dada, Oluwaseun Alexander, Ghazal, Awaisa, Kytölä, Anastasia, Weldatsadik, Rigbe, Donner, Kati, Loukola, Anu, Laiho, Päivi, Sistonen, Tuuli, Kaiharju, Essi, Laukkanen, Markku, Järvensivu, Elina, Lähteenmäki, Sini, Männikkö, Lotta, Wong, Regis, Toivola, Auli, Brunfeldt, Minna, Mattsson, Hannele, Koskelainen, Sami, Hiekkalinna, Tero, Paajanen, Teemu, Pärn, Kalle, Kals, Mart, Luo, Shuang, Padmanabhuni, Shanmukha Sampath, Niemi, Marianna, Gracia-Tabuenca, Javier, Helminen, Mika, Luukkaala, Tiina, Vähätalo, Iida, Tammerluoto, Jyrki, Smith, Sarah, Southerington, Tom, Lehto, Petri, Jones, Samuel E., Maisha, Fahrisa I., Strausz, Satu J., Lammi, Vilma, Cade, Brian E., Tervi, Anniina, Helaakoski, Viola, Broberg, Martin E., Lane, Jacqueline M., Redline, Susan, Saxena, Richa, and Ollila, Hanna M.
Published: 2023
Full Text: View/download PDF

26. Research performance and scholarly communication profile of competitive research funding: the case of Academy of Finland

Author: Pölönen, Janne and Auranen, Otto
Published: 2022
Full Text: View/download PDF

27. Whole genome sequencing reveals new links between spa t172/CC59 methicillin-resistant Staphylococcus aureus cases in low-endemicity region of Southwest Finland, 2007‒2016

Author: Jaakko Silvola, Kirsi Gröndahl-Yli-Hannuksela, Tiina Hirvioja, Kaisu Rantakokko-Jalava, Esa Rintala, Kari Auranen, Jenna Junnila, Harri Marttila, Laura Lindholm, and Jaana Vuopio
Subjects: Medicine, Science
Abstract: Abstract Methicillin-resistant Staphylococcus aureus (MRSA) rates have remained relatively low in Finland. In Southwest Finland, however, annual MRSA incidence increased from 12 to 25/100,000 between 2007 and 2016 with spa t172 strain causing one fourth (237/983) of all cases. This provoked us to study the molecular epidemiology of t172-MRSA, aiming to better understand the transmission of this strain type. We combined epidemiological data and whole genome sequencing (WGS) of a set of 64 (27%, 64/237) t172-MRSA isolates covering 10 years. Isolates represented sporadic and index cases of all identified healthcare-associated outbreaks (HAOs) and family clusters (FCs). Among the included 62 isolates, core-genome MLST analysis revealed eight genomic clusters comprising 24 (38.7%) isolates and 38 (61.3%) non-clustered isolates. Cluster 1 comprised ten and the remaining seven clusters two isolates each, respectively. Two epidemiologically distinct HAOs were linked in cluster 1. FCs were involved in all clusters. All strains were associated with epidemic clonal complex CC59. We were able to confirm the spread of several successful t172-MRSA subclones in regional healthcare and the community. WGS complemented routine surveillance by revealing undetected links between t172-MRSA cases. Targeted, WGS-based typing could enhance MRSA surveillance without the need for routine WGS diagnostics.
Published: 2022
Full Text: View/download PDF

28. NEB mutations disrupt the super-relaxed state of myosin and remodel the muscle metabolic proteome in nemaline myopathy

Author: Natasha Ranu, Jenni Laitila, Hannah F. Dugdale, Jennifer Mariano, Justin S. Kolb, Carina Wallgren-Pettersson, Nanna Witting, John Vissing, Juan Jesus Vilchez, Chiara Fiorillo, Edmar Zanoteli, Mari Auranen, Manu Jokela, Giorgio Tasca, Kristl G. Claeys, Nicol C. Voermans, Johanna Palmio, Sanna Huovinen, Maurizio Moggio, Thomas Nyegaard Beck, Aikaterini Kontrogianni-Konstantopoulos, Henk Granzier, and Julien Ochala
Subjects: Skeletal muscle, Nemaline myopathy, Nebulin, Myosin, Metabolism, Neurology. Diseases of the nervous system, RC346-429
Abstract: Abstract Nemaline myopathy (NM) is one of the most common non-dystrophic genetic muscle disorders. NM is often associated with mutations in the NEB gene. Even though the exact NEB-NM pathophysiological mechanisms remain unclear, histological analyses of patients’ muscle biopsies often reveal unexplained accumulation of glycogen and abnormally shaped mitochondria. Hence, the aim of the present study was to define the exact molecular and cellular cascade of events that would lead to potential changes in muscle energetics in NEB-NM. For that, we applied a wide range of biophysical and cell biology assays on skeletal muscle fibres from NM patients as well as untargeted proteomics analyses on isolated myofibres from a muscle-specific nebulin‐deficient mouse model. Unexpectedly, we found that the myosin stabilizing conformational state, known as super-relaxed state, was significantly impaired, inducing an increase in the energy (ATP) consumption of resting muscle fibres from NEB-NM patients when compared with controls or with other forms of genetic/rare, acquired NM. This destabilization of the myosin super-relaxed state had dynamic consequences as we observed a remodeling of the metabolic proteome in muscle fibres from nebulin‐deficient mice. Altogether, our findings explain some of the hitherto obscure hallmarks of NM, including the appearance of abnormal energy proteins and suggest potential beneficial effects of drugs targeting myosin activity/conformations for NEB-NM.
Published: 2022
Full Text: View/download PDF

29. Lowered oxidative capacity in spinal muscular atrophy, Jokela type; comparison with mitochondrial muscle disease

Author: Nadja Ratia, Edouard Palu, Hanna Lantto, Emil Ylikallio, Ritva Luukkonen, Anu Suomalainen, Mari Auranen, and Päivi Piirilä
Subjects: spinal muscular atrophy Jokela type (SMAJ), motoneuron disease, mitochondrial myopathy, cardiopulmonary exercise testing, lactate, Neurology. Diseases of the nervous system, RC346-429
Abstract: IntroductionSpinal muscular atrophy, Jokela type (SMAJ) is a rare autosomal dominantly hereditary form of spinal muscular atrophy caused by a point mutation c.197G>T in CHCHD10. CHCHD10 is known to be involved in the regulation of mitochondrial function even though patients with SMAJ do not present with multiorgan symptoms of mitochondrial disease. We aimed to characterize the cardiopulmonary oxidative capacity of subjects with SMAJ compared to healthy controls and patients with mitochondrial myopathy.MethodsEleven patients with genetically verified SMAJ, 26 subjects with mitochondrial myopathy (MM), and 28 healthy volunteers underwent a cardiopulmonary exercise test with lactate and ammonia sampling. The effect of the diagnosis group on the test results was analysed using a linear model.ResultsAdjusted for sex, age, and BMI, the SMAJ group had lower power output (p
Published: 2023
Full Text: View/download PDF

30. Deep Learning Test Platform for Maritime Applications: Development of the eM/S Salama Unmanned Surface Vessel and Its Remote Operations Center for Sensor Data Collection and Algorithm Development

Author: Juha Kalliovaara, Tero Jokela, Mehdi Asadi, Amin Majd, Juhani Hallio, Jani Auranen, Mika Seppänen, Ari Putkonen, Juho Koskinen, Tommi Tuomola, Reza Mohammadi Moghaddam, and Jarkko Paavola
Subjects: deep learning, multi-modal sensoring, datasets, unmanned surface vessel, remote operations center, situational awareness, Science
Abstract: In response to the global megatrends of digitalization and transportation automation, Turku University of Applied Sciences has developed a test platform to advance autonomous maritime operations. This platform includes the unmanned surface vessel eM/S Salama and a remote operations center, both of which are detailed in this article. The article highlights the importance of collecting and annotating multi-modal sensor data from the vessel. These data are vital for developing deep learning algorithms that enhance situational awareness and guide autonomous navigation. By securing relevant data from maritime environments, we aim to enhance the autonomous features of unmanned surface vessels using deep learning techniques. The annotated sensor data will be made available for further research through open access. An image dataset, which includes synthetically generated weather conditions, is published alongside this article. While existing maritime datasets predominantly rely on RGB cameras, our work underscores the need for multi-modal data to advance autonomous capabilities in maritime applications.
Published: 2024
Full Text: View/download PDF

31. Observation of the proton emitter $${}_{\,57}^{116}$$ 57 116 La59

Author: Wei Zhang, Bo Cederwall, Özge Aktas, Xiaoyu Liu, Aysegül Ertoprak, Ayse Nyberg, Kalle Auranen, Betool Alayed, Hussam Badran, Helen Boston, Maria Doncel, Ulrika Forsberg, Tuomas Grahn, Paul T. Greenlees, Song Guo, Jacob Heery, Joshua Hilton, David Jenkins, Rauno Julin, Sakari Juutinen, Minna Luoma, Olavi Neuvonen, Joonas Ojala, Robert D. Page, Janne Pakarinen, Jari Partanen, Edward S. Paul, Costel Petrache, Panu Rahkila, Panu Ruotsalainen, Mikael Sandzelius, Jan Sarén, Stuart Szwec, Holly Tann, Juha Uusitalo, and Robert Wadsworth
Subjects: Astrophysics, QB460-466, Physics, QC1-999
Abstract: Neutron-proton pairing is a topic of continuous interest in nuclear physics and open questions remain. The authors experimentally observe direct proton decay from the ground state of odd-odd 116La, providing support for the presence of strong neutron-proton pair correlations in this exotic, neutron deficient system.
Published: 2022
Full Text: View/download PDF

32. Towards waterless operations from mine to mill

Author: Luukkanen, Saija, Tanhua, Antti, Zhang, Zongxian, Mollehuara Canales, Raul, and Auranen, Ilpo
Published: 2022
Full Text: View/download PDF

33. In-beam γ94-ray spectroscopy of γ94Ag

Author: Pereira-López, X., Bentley, M. A., Wadsworth, R., Ruotsalainen, P., Lenzi, S. M., Forsberg, U., Auranen, K., Blazhev, A., Cederwall, B., Grahn, T., Greenlees, P., Illana, A., Jenkins, D. G., Julin, R., Jutila, H., Juutinen, S., Liu, X., Llewelyn, R., Luoma, M., Moschner, K., Müller-Gatermann, C., Singh, B. S. Nara, Nowacki, F., Ojala, J., Pakarinen, J., Papadakis, P., Rahkila, P., Romero, J., Sandzelius, M., Sarén, J., Tann, H., Uthayakumaar, S., Uusitalo, J., Vega-Romero, J. G., Vilhena, J. M., Yajzey, R., Zhang, W., and Zimba, G.
Published: 2023
Full Text: View/download PDF

34. Reassigning the shapes of the 0+ states in the 186Pb nucleus

Author: Joonas Ojala, Janne Pakarinen, Philippos Papadakis, Juha Sorri, Mikael Sandzelius, Daniel M. Cox, Kalle Auranen, Hussam Badran, Paul J. Davies, Tuomas Grahn, Paul T. Greenlees, Jack Henderson, Andrej Herzáň, Rolf-Dietmar Herzberg, Joshua Hilton, Ulrika Jakobsson, David G. Jenkins, David T. Joss, Rauno Julin, Sakari Juutinen, Tibor Kibédi, Joonas Konki, Gregory J. Lane, Matti Leino, Jarkko Liimatainen, Christopher G. McPeake, Olavi Neuvonen, Robert D. Page, Edward Parr, Jari Partanen, Pauli Peura, Panu Rahkila, John Revill, Panu Ruotsalainen, Jan Sarén, Catherine Scholey, Sanna Stolze, Juha Uusitalo, Andrew Ward, and Robert Wadsworth
Subjects: Astrophysics, QB460-466, Physics, QC1-999
Abstract: The authors study an interesting phenomena of shape coexistence in 186Pb. In an elegant and well-documented experiment, they confirm the coexistence of the three 0+ states in the 186Pb nucleus and reassign the shapes associated with the excited 0+ states.
Published: 2022
Full Text: View/download PDF

35. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

Author: Mahner, Sven, Reuss, Alexander, du Bois, Andreas, Grimm, Christoph, Marth, Christian, Berger, Regina, Concin, Nicole, Chang, Ting-Chang, Ochiai, Kazunori, Gebski, Val, Davis, Alison, Beale, Philip, Vergote, Ignace, Kridelka, Frédéric, Denys, Hannelore, Vandecaveye, Vincent, Candido dos Reis, Francisco Jose, Del Pilar Estevez Diz, Maria, Stuart, Gavin, MacKay, Helen, Carey, Mark, Cibula, David, Dundr (path), Pavel, Dorigo, Oliver, Berek, Jonathan, O'Donnell, Dearbhaile, Saadeh, Abu, Boere, Ingrid, Lok, Christianne, Coronado, Pluvio, Ottevanger, Nelleke, Tan, David SP, Ng, Joseph, Gonzalez Martin, Antonio, Oaknin, Ana, Poveda, Andres, Perez Fidalgo, Alejandro, Rauh-Hain, Alejandro, Lu, Karen, López-Zavala, Carlos, Gómez-García, Eva María, Ray-Coquard, Isabelle, Paoletti, Xavier, Kurtz, Jean-Emmanuel, Joly, Florence, Votan, Bénédicte, Bookman, Michael, Moore, Kathleen, Arend, Rebecca, Fujiwara, Keiichi, Fujiwara, Hiroyuki, Hasegawa, Kosei, Bruchim, Ilan, Tsoref, Dalia, Oda, Katsutoshi, Okamoto, Aikou, Enomoto, Takayuki, Michel, Dayana, Kim, Hee-Seung, Lee, Jung-Yun, Mukhopadhyay, Asima, Katsaros, Dionyssios, Colombo, Nicoletta, Pignata, Sandro, Lorusso, Domenica, Scambia, Giovanni, Kohn, Elise, Lee, Jung-Min, McNeish, Iain, Nicum, Shibani, Farrelly, Laura, Sehouli, Jalid, Keller, Maren, Braicu, Elena, Bjørge, Line, Mirza, Mansoor Raza, Auranen, Annika, Welch, Stephen, Oza, Amit M, Heinzelmann, Viola, Gourley, Charlie, Roxburgh, Patricia, Herrington, C Simon, Glasspool, Ros, Zang, Rongyu, Zhu, Jianqing, Gonzalez-Martin, Antonio, Kohn, Elise C, Berek, Jonathan S, Tan, David S P, Stuart, Gavin C E, and Bookman, Michael A
Published: 2022
Full Text: View/download PDF

36. Improved survival after implementation of ultra-radical surgery in advanced epithelial ovarian cancer: Results from a tertiary referral center

Author: Norppa, Niina, Staff, Synnove, Helminen, Mika, Auranen, Annika, and Saarelainen, Sami
Published: 2022
Full Text: View/download PDF

37. Hospital Visits Associated With Oral Infections in Patients With Neurofibromatosis Type 1: A Register‐Based Analysis.

Author: Reinhold, Vivian, Kallionpää, Roope A., Valtanen, Mikko, Auranen, Kari, Syrjänen, Stina, Peltonen, Sirkku, and Peltonen, Juha
Abstract: Various forms of oral involvement have been reported in patients with neurofibromatosis 1 (NF1). Here, we analyze register‐based associations between NF1 and hospital visits related to oral infections. The Finnish NF1 cohort encompasses all individuals with verified NF1 who have visited the Finnish central and university hospitals in 1987–2011. The Finnish Care Register for Health Care allowed the follow‐up of 1349 individuals with NF1, their 1894 siblings without NF1, and 13,870 matched controls for diagnoses related to oral infections in 1998–2014. We observed clearly increased hazards for hospital visits associated with dental caries (ICD‐10 K02; NF1 vs. controls, hazard ratio [HR] 4.42, 95% CI 3.23–6.04), diseases of pulp and periapical tissues (K04; HR 3.85, 95% CI 2.68–5.54), and gingivitis and periodontal diseases (K05; HR 3.63, 95% CI 2.37–5.56). In contrast, hospital visits related to diseases of salivary glands (K11), and stomatitis and related lesions (K12) did not show significantly increased hazard in NF1 compared with the controls or the non‐NF1 siblings. In conclusion, the findings suggest that hospital visits related to oral infections are relatively common among individuals with NF1. The results highlight the need for early detection, proactive prevention, and timely treatment of oral infections in individuals with NF1. [ABSTRACT FROM AUTHOR]
Published: 2025
Full Text: View/download PDF

38. A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer".

Author: Mirza, Mansoor R, Chase, Dana M, Slomovitz, Brian M, Christensen, René dePont, Novák, Zoltán, Black, Destin, Gilbert, Lucy, Sharma, Sudarshan, Valabrega, Giorgio, Landrum, Lisa M, Hanker, Lars C, Stuckey, Ashley, Boere, Ingrid, Gold, Michael A, Auranen, Annika, Pothuri, Bhavana, Cibula, David, McCourt, Carolyn, Raspagliesi, Francesco, and Shahin, Mark S
Abstract: Plain language summary What is this summary about? Dostarlimab, also known by the brand name JEMPERLI, is a medicine that uses a patient's own immune system to treat endometrial cancer. Dostarlimab is a type of medicine called an immunotherapy. Immunotherapies help the immune system find and attack cancer cells. Dostarlimab stops cancer cells from being able to hide from the immune system, which allows the patient to have a boosted immune response against their cancer. The RUBY study is a phase 3 clinical study of primary advanced (cancer that has spread outside the uterus) or recurrent (cancer that has come back) endometrial cancer. A phase 3 clinical study looks at how well a new treatment works compared to the standard, or usual, treatment in a large patient population. The RUBY study is testing how well dostarlimab given with chemotherapy, followed by dostarlimab alone, works at delaying primary advanced or recurrent endometrial cancer from getting worse and preventing patients from dying, compared to chemotherapy given alone (the current standard treatment for primary advanced or recurrent endometrial cancer). What were the results? When dostarlimab was given with chemotherapy, this combination was found to delay primary advanced or recurrent endometrial cancer from getting worse and to prevent patients from dying, compared with chemotherapy given alone (without dostarlimab). Patients in the study who received dostarlimab with chemotherapy had a 36% lower risk of dying or having their cancer get worse. What do the results mean? The results from this study contributed to the approval of dostarlimab with chemotherapy as a new treatment option for patients with mismatch repair deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer. As of the publication of this plain language summary of publication (PLSP), this combination of dostarlimab with chemotherapy has been approved in the United States of America, the United Kingdom, the European Union and Hong Kong. Clinical Trial Registration:NCT03981796 (RUBY) [ABSTRACT FROM AUTHOR]
Published: 2025
Full Text: View/download PDF

39. Direct measurement of three different deformations near the ground state in an atomic nucleus.

Author: Montes Plaza, Adrian, Pakarinen, Janne, Papadakis, Philippos, Herzberg, Rolf-Dietmar, Julin, Rauno, Rodríguez, Tomás R., Briscoe, Andrew D., Illana, Andrés, Ojala, Joonas, Ruotsalainen, Panu, Uusikylä, Eetu, Alayed, Betool, Alharbi, Ahmed, Alonso-Sañudo, Odette, Auranen, Kalle, Bogdanoff, Ville, Chadderton, Jamie, Esmaylzadeh, Arwin, Fransen, Christoph, and Grahn, Tuomas
Subjects: ATOMIC nucleus, PARTICLES (Nuclear physics), ISOTOPES, COINCIDENCE, PROBABILITY theory
Abstract: Atomic nuclei serve as prime laboratories for investigations of complex quantum phenomena, where minor nucleon rearrangements cause significant structural changes. 190Pb is the heaviest known neutron-deficient Pb isotope that can exhibit three distinct shapes: prolate, oblate, and spherical, with nearly degenerate excitation energies. Here we report on the combined results from three state-of-the-art measurements to directly observe these deformations in 190Pb. Contrary to earlier interpretations, we associate the collective yrast band as predominantly oblate, while the non-yrast band with higher collectivity follows characteristics of more deformed, predominantly prolate bands. Direct measurement of the E 0 ( 0 2 + → 0 1 + ) transition and γ-e− coincidence relations allowed us to locate and firmly assign the 0 2 + state in the level scheme and to discover a spherical 2 3 + state at 1281(1) keV with B (E 2 ; 2 3 + → 0 1 + ) = 1.2 (3) W.u. These assignments are based purely on observed transition probabilities and monopole strength values, and do not rely on model calculations for their interpretation. Direct measurements reveal that the neutron-deficient isotope 190Pb can adopt three different deformations near the ground state. The present work identifies the collective yrast band as predominantly oblate, the non-yrast band as predominantly prolate, and discovers a candidate spherical 2 3 + state at 1281 keV. [ABSTRACT FROM AUTHOR]
Published: 2025
Full Text: View/download PDF

40. γ-Ray spectroscopy above the 9+ isomeric state in the N = Z nucleus 66As.

Author: Joukainen, Henna, Ruotsalainen, Panu, Sarén, Jan, Srivastava, Praveen C., Patel, Deepak, Julin, Rauno, Auranen, Kalle, Ge, Zhuang, Grahn, Tuomas, Greenlees, Paul, Illana, Andres, Jutila, Henri, Leino, Matti, Louko, Jussi, Luoma, Minna, Ojala, Joonas, Pakarinen, Janne, Rahkila, Panu, Sandzelius, Mikael, and Tann, Holly
Subjects: HEAVY ion fusion reactions, EXCITED states, ISOMERS, DETECTORS, ELECTRONS
Abstract: Excited states above the 9 + isomer in the odd-odd N = Z nucleus 66 As were studied by employing the 40 Ca( 28 Si, pn) fusion-evaporation reaction at the Accelerator Laboratory of the University of Jyväskylä, Finland. A key method in this study was the use of conversion electrons emitted in the de-excitation of the isomeric state in 66 As as a tag for prompt γ rays. Several new states have been added to the 66 As level scheme, which was extended up to a tentative spin of 23 ħ . The previously reported even-spin yrast band has been reassigned to have odd spin values. The odd-spin states above the 9 + isomer are compared with shell-model calculations using the jj44b and JUN45 interactions. Additionally, the recoil- β tagging efficiency of the recently developed scintillator detector named Tuike has been determined experimentally for the first time. [ABSTRACT FROM AUTHOR]
Published: 2024
Full Text: View/download PDF

41. Risk of Midlife Stroke After Adverse Pregnancy Outcomes: The FinnGen Study

Author: Miller, Eliza C., Kauko, Anni, Tom, Sarah E., Laivuori, Hannele, Niiranen, Teemu, Bello, Natalie A., Palotie, Aarno, Daly, Mark, Riley-Gills, Bridget, Jacob, Howard, Paul, Dirk, Matakidou, Athena, Platt, Adam, Runz, Heiko, John, Sally, Okafo, George, Lawless, Nathan, Salminen-Mankonen, Heli, Plenge, Robert, Maranville, Joseph, McCarthy, Mark, Hunkapiller, Julie, Ehm, Margaret G., Auro, Kirsi, Longerich, Simonne, Fox, Caroline, Mälarstig, Anders, Klinger, Katherine, Raipal, Deepak, Green, Eric, Graham, Robert, Yang, Robert, Donnell, Chris O´, Mäkelä, Tomi P., Kaprio, Jaakko, Virolainen, Petri, Hakanen, Antti, Kilpi, Terhi, Perola, Markus, Partanen, Jukka, Pitkäranta, Anne, Raivio, Taneli, Serpi, Raisa, Laitinen, Tarja, Kosma, Veli-Matti, Laukkanen, Jari, Hautalahti, Marco, Tuovila, Outi, Pakkanen, Raimo, Waring, Jeffrey, Riley-Gillis, Bridget, Rahimov, Fedik, Tachmazidou, Ioanna, Chen, Chia-Yen, Runz, Heiko, Ding, Zhihao, Jung, Marc, Biswas, Shameek, Pendergrass, Rion, Hunkapiller, Julie, Ehm, Margaret G., Pulford, David, Raghavan, Neha, Huertas-Vazquez, Adriana, Sul, Jae-Hoon, Mälarstig, Anders, Hu, Xinli, Klinger, Katherine, Graham, Robert, Green, Eric, Mozaffari, Sahar, Waterworth, Dawn, Renaud, Nicole, Obeidat, Ma´en, Ripatti, Samuli, Schleutker, Johanna, Perola, Markus, Arvas, Mikko, Carpén, Olli, Hinttala, Reetta, Kettunen, Johannes, Mannermaa, Arto, Aalto-Setälä, Katriina, Kähönen, Mika, Laukkanen, Jari, Mäkelä, Johanna, Kälviäinen, Reetta, Julkunen, Valtteri, Soininen, Hilkka, Remes, Anne, Hiltunen, Mikko, Peltola, Jukka, Raivio, Minna, Tienari, Pentti, Rinne, Juha, Kallionpää, Roosa, Partanen, Juulia, Abbasi, Ali, Ziemann, Adam, Smaoui, Nizar, Lehtonen, Anne, Eaton, Susan, Runz, Heiko, Lahdenperä, Sanni, Biswas, Shameek, Hunkapiller, Julie, Bowers, Natalie, Teng, Edmond, Pendergrass, Rion, Xu, Fanli, Pulford, David, Auro, Kirsi, Addis, Laura, Eicher, John, Li, Qingqin S, He, Karen, Khramtsova, Ekaterina, Raghavan, Neha, Färkkilä, Martti, Koskela, Jukka, Pikkarainen, Sampsa, Jussila, Airi, Kaukinen, Katri, Blomster, Timo, Kiviniemi, Mikko, Voutilainen, Markku, Daly, Mark, Abbasi, Ali, Waring, Jeffrey, Smaoui, Nizar, Rahimov, Fedik, Lehtonen, Anne, Lu, Tim, Bowers, Natalie, Pendergrass, Rion, McCarthy, Linda, Hart, Amy, Guan, Meijian, Miller, Jason, Kalpala, Kirsi, Miller, Melissa, Hu, Xinli, Eklund, Kari, Palomäki, Antti, Isomäki, Pia, Pirilä, Laura, Kaipiainen-Seppänen, Oili, Huhtakangas, Johanna, Mars, Nina, Abbasi, Ali, Waring, Jeffrey, Rahimov, Fedik, Lertratanakul, Apinya, Smaoui, Nizar, Lehtonen, Anne, Hochfeld, Marla, Bowers, Natalie, Pendergrass, Rion, Esparza Gordillo, Jorge, Auro, Kirsi, Waterworth, Dawn, Farias, Fabiana, Kalpala, Kirsi, Bing, Nan, Hu, Xinli, Laitinen, Tarja, Pelkonen, Margit, Kauppi, Paula, Kankaanranta, Hannu, Harju, Terttu, Lahesmaa, Riitta, Smaoui, Nizar, Lassi, Glenda, Eaton, Susan, Chen, Hubert, Pendergrass, Rion, Bowers, Natalie, Betts, Joanna, Auro, Kirsi, Mishra, Rajashree, Mouded, Majd, Ngo, Debby, Vaura, Felix, Salomaa, Veikko, Metsärinne, Kaj, Aittokallio, Jenni, Kähönen, Mika, Hernesniemi, Jussi, Gordin, Daniel, Sinisalo, Juha, Taskinen, Marja-Riitta, Tuomi, Tiinamaija, Hiltunen, Timo, Laukkanen, Jari, Elliott, Amanda, Pat Reeve, Mary, Ruotsalainen, Sanni, Challis, Benjamin, Paul, Dirk, Hunkapiller, Julie, Bowers, Natalie, Pendergrass, Rion, Chu, Audrey, Auro, Kirsi, Reilly, Dermot, Mendelson, Mike, Parkkinen, Jaakko, Miller, Melissa, Meretoja, Tuomo, Joensuu, Heikki, Carpén, Olli, Mattson, Johanna, Salminen, Eveliina, Auranen, Annika, Karihtala, Peeter, Elenius, Päivi Auvinen Klaus, Schleutker, Johanna, Pitkänen, Esa, Mars, Nina, Daly, Mark, Popovic, Relja, Waring, Jeffrey, Riley-Gillis, Bridget, Lehtonen, Anne, Schutzman, Jennifer, Hunkapiller, Julie, Bowers, Natalie, Pendergrass, Rion, Kulkarni, Diptee, Auro, Kirsi, Porello, Alessandro, Loboda, Andrey, Lehtonen, Heli, McDonough, Stefan, Vuoti, Sauli, Kaarniranta, Kai, Turunen, Joni A, Ollila, Terhi, Uusitalo, Hannu, Karjalainen, Juha, Pitkänen, Esa, Liu, Mengzhen, Runz, Heiko, Loomis, Stephanie, Strauss, Erich, Bowers, Natalie, Chen, Hao, Pendergrass, Rion, Tasanen, Kaisa, Huilaja, Laura, Hannula-Jouppi, Katariina, Salmi, Teea, Peltonen, Sirkku, Koulu, Leena, Smaoui, Nizar, Rahimov, Fedik, Lehtonen, Anne, Choy, David, Pendergrass, Rion, Waterworth, Dawn, Kalpala, Kirsi, Wu, Ying, Pussinen, Pirkko, Salminen, Aino, Salo, Tuula, Rice, David, Nieminen, Pekka, Palotie, Ulla, Siponen, Maria, Suominen, Liisa, Mäntylä, Päivi, Gursoy, Ulvi, Anttonen, Vuokko, Sipilä, Kirsi, Pendergrass, Rion, Kurra, Venla, Kotaniemi-Talonen, Laura, Heikinheimo, Oskari, Kalliala, Ilkka, Aaltonen, Lauri, Jokimaa, Varpu, Kettunen, Johannes, Vääräsmäki, Marja, Uimari, Outi, Morin-Papunen, Laure, Niinimäki, Maarit, Piltonen, Terhi, Kivinen, Katja, Widen, Elisabeth, Tukiainen, Taru, Pat Reeve, Mary, Daly, Mark, Välimäki, Niko, Laakkonen, Eija, Tyrmi, Jaakko, Silven, Heidi, Sliz, Eeva, Arffman, Riikka, Savukoski, Susanna, Laisk, Triin, Pujol, Natalia, Liu, Mengzhen, Riley-Gillis, Bridget, Pendergrass, Rion, Kumar, Janet, Auro, Kirsi, Hovatta, Iiris, Chen, Chia-Yen, Isometsä, Erkki, Ollila, Hanna, Suvisaari, Jaana, Damm Als, Thomas, Mäkitie, Antti, Bizaki-Vallaskangas, Argyro, Toppila-Salmi, Sanna, Willberg, Tytti, Saarentaus, Elmo, Aarnisalo, Antti, Salminen, Eveliina, Rahikkala, Elisa, Kettunen, Johannes, Aittomäki, Kristiina, Åberg, Fredrik, Kurki, Mitja, Ripatti, Samuli, Daly, Mark, Karjalainen, Juha, Havulinna, Aki, Mehtonen, Juha, Palta, Priit, Hassan, Shabbeer, Della, Pietro, Parolo, Briotta, Zhou, Wei, Maasha, Mutaamba, Hassan, Shabbeer, Lemmelä, Susanna, Rivas, Manuel, Niemi, Mari E., Palotie, Aarno, Liu, Aoxing, Lehisto, Arto, Ganna, Andrea, Llorens, Vincent, Tukiainen, Taru, Pat Reeve, Mary, Heyne, Henrike, Mars, Nina, Rämö, Joel, Saarentaus, Elmo, Ollila, Hanna, Rodosthenous, Rodos, Strausz, Satu, Palotie, Tuula, Palin, Kimmo, Garcia-Tabuenca, Javier, Siirtola, Harri, Kiiskinen, Tuomo, Lee, Jiwoo, Tsuo, Kristin, Elliott, Amanda, Kristiansson, Kati, Arvas, Mikko, Hyvärinen, Kati, Ritari, Jarmo, Carpén, Olli, Kettunen, Johannes, Pylkäs, Katri, Sliz, Eeva, Karjalainen, Minna, Mantere, Tuomo, Kangasniemi, Eeva, Heikkinen, Sami, Mannermaa, Arto, Laakkonen, Eija, Pitkänen, Nina, Lessard, Samuel, Chatelain, Clément, Terho, Perttu, Soini, Sirpa, Partanen, Jukka, Punkka, Eero, Serpi, Raisa, Siltanen, Sanna, Kosma, Veli-Matti, Kuopio, Teijo, Jalanko, Anu, Shen, Huei-Yi, Kajanne, Risto, Aavikko, Mervi, Palin, Henna, Linna, Malla-Maria, Kurki, Mitja, Karjalainen, Juha, Della, Pietro, Parolo, Briotta, Lehisto, Arto, Mehtonen, Juha, Zhou, Wei, Kanai, Masahiro, Maasha, Mutaamba, Havulinna, Aki, Lemmelä, Susanna, Kiiskinen, Tuomo, Elisa Lahtela, L., Kaunisto, Mari, Kilpeläinen, Elina, Sipilä, Timo P., Alexander Dada, Oluwaseun, Ghazal, Awaisa, Kytölä, Anastasia, Weldatsadik, Rigbe, Ruotsalainen, Sanni, Donner, Kati, Sipilä, Timo P., Loukola, Anu, Laiho, Päivi, Sistonen, Tuuli, Kaiharju, Essi, Laukkanen, Markku, Järvensivu, Elina, Lähteenmäki, Sini, Männikkö, Lotta, Wong, Regis, Toivola, Auli, Brunfeldt, Minna, Mattsson, Hannele, Kristiansson, Kati, Lemmelä, Susanna, Koskelainen, Sami, Hiekkalinna, Tero, Paajanen, Teemu, Palta, Priit, Pärn, Kalle, Kals, Mart, Luo, Shuang, Laitinen, Tarja, Pat Reeve, Mary, Sampath Padmanabhuni, Shanmukha, Niemi, Marianna, Siirtola, Harri, Gracia-Tabuenca, Javier, Helminen, Mika, Luukkaala, Tiina, Vähätalo, Iida, Pitkänen, Jyrki, Hautalahti, Marco, Mäkelä, Johanna, Smith, Sarah, and Southerington, Tom
Published: 2023
Full Text: View/download PDF

42. Effects of physical activity intervention on 24-h movement behaviors: a compositional data analysis

Author: Jesse Pasanen, Tuija Leskinen, Kristin Suorsa, Anna Pulakka, Joni Virta, Kari Auranen, and Sari Stenholm
Subjects: Medicine, Science
Abstract: Abstract We utilized compositional data analysis (CoDA) to study changes in the composition of the 24-h movement behaviors during an activity tracker based physical activity intervention. A total of 231 recently retired Finnish retirees were randomized into intervention and control groups. The intervention participants were requested to use a commercial activity tracker bracelet with daily activity goal and inactivity alerts for 12 months. The controls received no intervention. The 24-h movement behaviors, i.e., sleep, sedentary time (SED), light physical activity (LPA), and moderate-to-vigorous physical activity (MVPA) were estimated from wrist-worn ActiGraph data using the GGIR R-package. Three balance coordinates describing the composition of movement behaviors were applied: ratio of active vs. passive behaviors, LPA vs. MVPA, and sleep vs. SED. A linear mixed model was used to study changes between the baseline and 6-month time point. Overall, the changes in the 24-h movement behaviors were small and did not differ between the groups. Only the ratio of LPA to MVPA tended to change differently between the groups (group*time interaction p = 0.08) as the intervention group increased LPA similarly to controls but decreased their MVPA. In conclusion, the use of a commercial activity tracker may not be enough to induce changes in the 24-h movement behaviors among retirees.
Published: 2022
Full Text: View/download PDF

43. Underreporting of SARS-CoV-2 infections during the first wave of the 2020 COVID-19 epidemic in Finland-Bayesian inference based on a series of serological surveys.

Author: Tuomo A Nieminen, Kari Auranen, Sangita Kulathinal, Tommi Härkänen, Merit Melin, Arto A Palmu, and Jukka Jokinen
Subjects: Medicine, Science
Abstract: In Finland, the first wave of the COVID-19 epidemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) took place from March to June 2020, with the majority of COVID-19 cases diagnosed in the Helsinki-Uusimaa region. The magnitude and trend in the incidence of COVID-19 is one way to monitor the course of the epidemic. The diagnosed COVID-19 cases are a subset of the infections and therefore the COVID-19 incidence underestimates the SARS-CoV-2 incidence. The likelihood that an individual with SARS-CoV-2 infection is diagnosed with COVID-19 depends on the clinical manifestation as well as the infection testing policy and capacity. These factors may fluctuate over time and the underreporting of infections changes accordingly. Quantifying the extent of underreporting allows the assessment of the true incidence of infection. To obtain information on the incidence of SARS-CoV-2 infection in Finland, a series of serological surveys was initiated in April 2020. We develop a Bayesian inference approach and apply it to data from the serological surveys, registered COVID-19 cases, and external data on antibody development, to estimate the time-dependent underreporting of SARS-Cov-2 infections during the first wave of the COVID-19 epidemic in Finland. During the entire first wave, there were 1 to 5 (95% probability) SARS-CoV-2 infections for every COVID-19 case. The underreporting was highest before April when there were 4 to 17 (95% probability) infections for every COVID-19 case. It is likely that between 0.5%-1.0% (50% probability) and no more than 1.5% (95% probability) of the adult population in the Helsinki-Uusimaa region were infected with SARS-CoV-2 by the beginning of July 2020.
Published: 2023
Full Text: View/download PDF

44. Cohort study design for estimating the effectiveness of seasonal influenza vaccines in real time based on register data : The Finnish example

Author: BAUM, ULRIKE, AURANEN, KARI, KULATHINAL, SANGITA, SYRJÄNEN, RITVA, NOHYNEK, HANNA, and JOKINEN, JUKKA
Published: 2020

45. IMPDH2: a new gene associated with dominant juvenile-onset dystonia-tremor disorder

Author: Kuukasjärvi, Anna, Landoni, Juan C., Kaukonen, Jyrki, Juhakoski, Mika, Auranen, Mari, Torkkeli, Tommi, Velagapudi, Vidya, and Suomalainen, Anu
Published: 2021
Full Text: View/download PDF

46. Increased risk for dementia in neurofibromatosis type 1

Author: Kallionpää, Roope A., Valtanen, Mikko, Auranen, Kari, Uusitalo, Elina, Rinne, Juha O., Peltonen, Sirkku, and Peltonen, Juha
Published: 2021
Full Text: View/download PDF

47. Modified Atkins diet modifies cardiopulmonary exercise characteristics and promotes hyperventilation in healthy subjects

Author: Ratia, Nadja, Pietiläinen, Kirsi H., Auranen, Mari, Saksa, Lauri, Luukkonen, Ritva, Suomalainen, Anu, and Piirilä, Päivi
Published: 2021
Full Text: View/download PDF

48. Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report

Author: Dominguez-Valentin, Mev, Crosbie, Emma J., Engel, Christoph, Aretz, Stefan, Macrae, Finlay, Winship, Ingrid, Capella, Gabriel, Thomas, Huw, Nakken, Sigve, Hovig, Eivind, Nielsen, Maartje, Sijmons, Rolf H., Bertario, Lucio, Bonanni, Bernardo, Tibiletti, Maria Grazia, Cavestro, Giulia Martina, Mints, Miriam, Gluck, Nathan, Katz, Lior, Heinimann, Karl, Vaccaro, Carlos A., Green, Kate, Lalloo, Fiona, Hill, James, Schmiegel, Wolff, Vangala, Deepak, Perne, Claudia, Strauß, Hans-Georg, Tecklenburg, Johanna, Holinski-Feder, Elke, Steinke-Lange, Verena, Mecklin, Jukka-Pekka, Plazzer, John-Paul, Pineda, Marta, Navarro, Matilde, Vidal, Joan Brunet, Kariv, Revital, Rosner, Guy, Piñero, Tamara Alejandra, Gonzalez, María Laura, Kalfayan, Pablo, Ryan, Neil, ten Broeke, Sanne W., Jenkins, Mark A., Sunde, Lone, Bernstein, Inge, Burn, John, Greenblatt, Marc, de Vos tot Nederveen Cappel, Wouter H., Della Valle, Adriana, Lopez-Koestner, Francisco, Alvarez, Karin, Büttner, Reinhard, Görgens, Heike, Morak, Monika, Holzapfel, Stefanie, Hüneburg, Robert, von Knebel Doeberitz, Magnus, Loeffler, Markus, Rahner, Nils, Weitz, Jürgen, Pylvänäinen, Kirsi, Renkonen-Sinisalo, Laura, Lepistö, Anna, Auranen, Annika, Hopper, John L., Win, Aung Ko, Haile, Robert W., Lindor, Noralane M., Gallinger, Steven, Le Marchand, Loïc, Newcomb, Polly A., Figueiredo, Jane C., Thibodeau, Stephen N., Therkildsen, Christina, Okkels, Henrik, Ketabi, Zohreh, Denton, Oliver G., Rødland, Einar Andreas, Vasen, Hans, Neffa, Florencia, Esperon, Patricia, Tjandra, Douglas, Möslein, Gabriela, Sampson, Julian R., Evans, D. Gareth, Seppälä, Toni T., and Møller, Pål
Published: 2021
Full Text: View/download PDF

49. Experimental observation of the M1 scissors mode in 254No

Author: F.L. Bello Garrote, A. Lopez-Martens, A.C. Larsen, I. Deloncle, S. Péru, F. Zeiser, P.T. Greenlees, B.V. Kheswa, K. Auranen, D.L. Bleuel, D.M. Cox, L. Crespo Campo, F. Giacoppo, A. Görgen, T. Grahn, M. Guttormsen, T.W. Hagen, L. Harkness-Brennan, K. Hauschild, G. Henning, R.-D. Herzberg, R. Julin, S. Juutinen, T.A. Laplace, M. Leino, J.E. Midtbø, V. Modamio, J. Pakarinen, P. Papadakis, J. Partanen, T. Renstrøm, K. Rezynkina, M. Sandzelius, J. Sarén, C. Scholey, S. Siem, J. Sorri, S. Stolze, and J. Uusitalo
Subjects: Scissors mode, γ-strength function, Transfermium nuclides, Physics, QC1-999
Abstract: We present the first experimental evidence of the scissors mode in the superheavy nucleus 254No produced in the 208Pb(48Ca, 2nγ))254No reaction. The spectrum of γ rays emitted by the excited 254No nuclei shows an enhanced γ-ray yield for transition energies of ≈2.5 MeV. By measuring the linear polarization properties of the emitted γ rays, we confirm that the transitions in the enhancement region are predominantly of magnetic-dipole character, characteristic for the scissors mode. To further characterize the enhanced γ-ray yield, simulations of the electromagnetic decay of 254No were performed. The observed enhancement is reproduced by including an M1 component in the γ strength function with total strength B(M1↑)=11.8(19)μN2. This is in good agreement with the integrated M1 strength from sum-rule estimates and new calculations within the quasi-particle random-phase approximation presented here. Our results provide a stringent test of phenomenological formulae for the scissors mode currently used in stellar nucleosynthesis calculations. We find that those formulae are not satisfactory, and we recommend using sum-rule estimates assuming a rigid-body moment of inertia instead for describing the scissors mode in superheavy nuclei.
Published: 2022
Full Text: View/download PDF

50. Recontacting biobank participants to collect lifestyle, behavioural and cognitive information via online questionnaires: lessons from a pilot study within FinnGen

Author: Oskari Heikinheimo, Athena Matakidou, Jaakko Kaprio, Ying Wu, Kai Kaarniranta, Peeter Karihtala, Wei Zhou, Caroline Fox, Sarah Smith, Apinya Lertratanakul, Katri Kaukinen, Johannes Kettunen, Eeva Sliz, Markus Perola, Veikko Salomaa, Hilkka Soininen, Ilkka Kalliala, Mika Kähönen, Hao Chen, Andrey Loboda, Laure Morin-Papunen, Terhi Piltonen, Anders Mälarstig, Jason Miller, Jussi Hernesniemi, Henrike Heyne, Sirkku Peltonen, Daniel Gordin, Masahiro Kanai, Benjamin Challis, Juha Sinisalo, David Rice, Fredrik Åberg, Aarno Palotie, Samuli Ripatti, Oili Kaipiainen-Seppänen, Aki Havulinna, Satu Strausz, Tuomo Kiiskinen, Sanni Ruotsalainen, Jukka Koskela, Tuula Palotie, Mark Daly, Howard Jacob, Heiko Runz, Sally John, Robert Plenge, Mark McCarthy, Julie Hunkapiller, Dawn Waterworth, Petri Virolainen, Terhi Kilpi, Jukka Partanen, Anne Pitkäranta, Veli-Matti Kosma, Outi Tuovila, Raimo Pakkanen, Shameek Biswas, Xinli Hu, Johanna Schleutker, Mikko Arvas, Olli Carpen, Reetta Hinttala, Arto Mannermaa, Valtteri Julkunen, Anne Remes, Reetta Kälviäinen, Mikko Hiltunen, Jukka Peltola, Pentti Tienari, Juha Rinne, Adam Ziemann, Jeffrey Waring, Nizar Smaoui, Anne Lehtonen, Susan Eaton, Sanni Lahdenperä, Natalie Bowers, Edmond Teng, Fanli Xu, David Pulford, Martti Färkkilä, Sampsa Pikkarainen, Airi Jussila, Timo Blomster, Mikko Kiviniemi, Markku Voutilainen, Fedik Rahimov, Joseph Maranville, Tim Lu, Kirsi Kalpala, Melissa Miller, Linda McCarthy, Kari Eklund, Antti Palomäki, Pia Isomäki, Laura Pirilä, Johanna Huhtakangas, Marla Hochfeld, Nan Bing, Jorge Esparza Gordillo, Nina Mars, Tarja Laitinen, Margit Pelkonen, Paula Kauppi, Hannu Kankaanranta, Terttu Harju, Hubert Chen, Teemu Niiranen, Kaj Metsärinne, Marja-Riitta Taskinen, Tiinamaija Tuomi, Jari Laukkanen, Audrey Chu, Jaakko Parkkinen, Heikki Joensuu, Tuomo Meretoja, Lauri Aaltonen, Annika Auranen, Päivi Auvinen, Klaus Elenius, Relja Popovic, Jennifer Schutzman, Heli Lehtonen, Stefan McDonough, Diptee Kulkarni, Terhi Ollila, Hannu Uusitalo, Erich Strauss, Kaisa Tasanen, Laura Huilaja, Katariina Hannula-Jouppi, Teea Salmi, Leena Koulu, David Choy, Anu Jalanko, Risto Kajanne, Mari Kaunisto, Chia-Yen Chen, Robert Yang, Kirsi Auro, Clement Chatelain, Mitja Kurki, Juha Karjalainen, Kimmo Palin, Priit Palta, Susanna Lemmelä, Manuel Rivas, Arto Lehisto, Andrea Ganna, Vincent Llorens, Kati Kristiansson, Kati Hyvärinen, Jarmo Ritari, Katri Pylkäs, Minna Karjalainen, Tuomo Mantere, Eeva Kangasniemi, Sami Heikkinen, Eija Laakkonen, Anu Loukola, Päivi Laiho, Tuuli Sistonen, Essi Kaiharju, Markku Laukkanen, Elina Järvensivu, Sini Lähteenmäki, Lotta Männikkö, Regis Wong, Hannele Mattsson, Kati Donner, Kalle Pärn, Elina Kilpeläinen, Hannele Laivuori, Harri Siirtola, Lila Kallio, Sirpa Soini, Teijo Kuopio, Ioanna Tachmazidou, Katja Kivinen, Pekka Nieminen, Adam Platt, Sanna Toppila-Salmi, Antti Mäkitie, Elmo Saarentaus, Kristiina Aittomäki, Elisabeth Widen, Marja Vääräsmäki, Erkki Isometsä, Jari Lahti, Laura Addis, Taneli Raivio, Mart Kals, Majd Mouded, Hanna Ollila, Vuokko Anttonen, Robert Graham, Amanda Elliott, Ali Abbasi, Bridget Riley-Gills, Dirk Paul, Katherine Klinger, Deepak Raipal, Antti Hakanen, Raisa Serpi, Johanna Mäkelä, Mengzhen Liu, Neha Raghavan, Adriana Huertas-Vazquez, Nicole Renaud, Roosa Kallionpää, John Eicher, Minna Raivio, Juulia Partanen, Riitta Lahesmaa, Glenda Lassi, Joanna Betts, Rajashree Mishra, Felix Vaura, Joel Rämö, Mary Pat Reeve, Johanna Mattson, Sauli Vuoti, Esa Pitkänen, Joni A Turunen, Stephanie Loomis, Pirkko Pussinen, Aino Salminen, Tuula Salo, Ulla Palotie, Maria Siponen, Liisa Suominen, Päivi Mäntylä, Ulvi Gursoy, Kirsi Sipilä, Venla Kurra, Laura Kotaniemi-Talonen, Outi Uimari, Taru Tukiainen, Niko Välimäki, Janet Kumar, Juha Mehtonen, Shabbeer Hassan, Pietro Della Briotta Parolo, Mutaamba Maasha, Javier Garcia-Tabuenca, Jiwoo Lee, Kristin Tsuo, Nina Pitkänen, Eero Punkka, Huei-Yi Shen, Mervi Aavikko, L. Elisa Lahtela, Timo P. Sipilä, Awaisa Ghazal, Sami Koskelainen, Teemu Paajanen, Shuang Luo, Tiina Luukkaala, Iida Vähätalo, Tero Jyrhämä, Marco Hautalahti, Tom Southerington, Jaana Suvisaari, Zhihao Ding, Qingqin S Li, Amy Hart, Rodosthenis S Rodosthenous, Mari E K Niemi, Merja Perala, Perttu Terho, Theresa Knopp, Enni M Makkonen, Paula Nurmi, Pauli Wihuri, Corianna Moffatt, Paolo Martini, Laura Germine, Viola A Makela, Oona A Karhunen, Tero S Hiekkalinna, Alessandro Porello, Anastasia Kytölä, Antti Aarnisalo, Aoxing Liu, Argyro Bizaki-Vallaskangas, Auli Toivola, Debby Ngo, Dermot Reilly, Ekaterina Khramtsova, Elisa Rahikkala, Eric Green, Eveliina Salminen, Fabiana Farias, George Okafo, Heidi Silven, Heli Salminen-Mankonen, Henna Palin, Iiris Hovatta, Jaakko Tyrmi, Jae-Hoon Sul, Jenni Aittokallio, Jyrki Pitkänen, Karen He, Katriina Aalto-Setälä, Maarit Niinimäki, Malla-Maria Linna, Marc Jung, Margaret G. Ehm, Marianna Niemi, Meijian Guan, Mike Mendelson, Minna Brunfeldt, Natalia Pujol, Nathan Lawless, Oluwaseun Alexander Dada, Rigbe Weldatsadik, Riikka Arffman, Rion Pendergrass, Sahar Mozaffari, Samuel Lessard, Sanna Siltanen, Shanmukha Sampath Padmanabhuni, Simonne Longerich, Susanna Savukoski, Thomas Damm Als, Timo Hiltunen, Tomi P. Mäkelä, Triin Laisk, Tytti Willberg, and Varpu Jokimaa
Subjects: Medicine
Abstract: Objectives To recontact biobank participants and collect cognitive, behavioural and lifestyle information via a secure online platform.Design Biobank-based recontacting pilot study.Setting Three Finnish biobanks (Helsinki, Auria, Tampere) recruiting participants from February 2021 to July 2021.Participants All eligible invitees were enrolled in FinnGen by their biobanks (Helsinki, Auria, Tampere), had available genetic data and were >18 years old. Individuals with severe neuropsychiatric disease or cognitive or physical disabilities were excluded. Lastly, 5995 participants were selected based on their polygenic score for cognitive abilities and invited to the study. Among invitees, 1115 had successfully participated and completed the study questionnaire(s).Outcome measures The primary outcome was the participation rate among study invitees. Secondary outcomes included questionnaire completion rate, quality of data collected and comparison of participation rate boosting strategies.Results The overall participation rate was 18.6% among all invitees and 23.1% among individuals aged 18–69. A second reminder letter yielded an additional 9.7% participation rate in those who did not respond to the first invitation. Recontacting participants via an online healthcare portal yielded lower participation than recontacting via physical letter. The completion rate of the questionnaire and cognitive tests was high (92% and 85%, respectively), and measurements were overall reliable among participants. For example, the correlation (r) between self-reported body mass index and that collected by the biobanks was 0.92.Conclusion In summary, this pilot suggests that recontacting FinnGen participants with the goal to collect a wide range of cognitive, behavioural and lifestyle information without additional engagement results in a low participation rate, but with reliable data. We suggest that such information be collected at enrolment, if possible, rather than via post hoc recontacting.
Published: 2022
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Publication Type

Journal

Region

Database

Publisher

666 results on '"Auranen A"'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources